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ABSTRACT 
 
The World Health Organisation (WHO) estimates that at least 75% of infants receive 
infant formula milk (IFM) either entirely or in conjunction with breast milk during the first 
four months after birth.  The presence of the emerging pathogen Enterobacter sakazakii 
in IFM has been associated with rare but fatal cases of neonatal infections and deaths.  
There is thus a need for accurate methods for the rapid detection of E. sakazakii in 
foods.  At present, the methods used to detect and identify this micro-organism are 
inadequate, controversial and contradictory.  The aim of this study was to determine the 
most suitable method for E. sakazakii detection after evaluation of the currently 
available methods.  A further aim was to optimise a polymerase chain reaction (PCR) 
method for the detection of only viable E. sakazakii cells utilising the DNA-intercalating 
dyes ethidium monoazide (EMA) and propidium monoazide (PMA).  
The Food and Drug Administration (FDA) method for E. sakazakii detection was 
utilised to select 50 isolates from IFM and 14 from the environment, regardless of 
colony appearance.  These isolates were identified by sequencing a 1.5 kilobase (kb) 
fragment of the 16S ribosomal DNA (rDNA) and by using the National Centre for 
Biotechnological Information (NCBI) database to confirm the closet known relatives.  
Seven of the 50 (14%) IFM isolates and six of the 14 (43%) environmental isolates were 
identified as E. sakazakii.  The methods that were evaluated for accuracy in detecting 
and identifying these E. sakazakii isolates included yellow pigment production on 
tryptone soy agar (TSA), chromogenic Druggan-Forsythe-Iversen (DFI) and 
Enterobacter sakazakii (ES) agars and PCR using six different species-specific primer 
pairs described in the literature.   
The suitability of the FDA method was lowered by the low sensitivity, specificity 
and accuracy (87%, 71% and 74%, respectively) of using yellow pigment production for 
E. sakazakii identification.  DFI and ES agars were shown to be sensitive, specific and 
accurate (100%, 98% and 98%, respectively) for the detection of E. sakazakii.  The 
specificity of the PCR amplifications was found to vary between 8% and 92%, with 
Esakf and Esakr being the most accurate of the primer pairs evaluated.   
The current FDA method for E. sakazakii detection requires revision in the light of 
the availability of more sensitive, specific and accurate detection methods.  Based on 
the results obtained in this study, a new method is proposed for the detection of  
E. sakazakii in food and environmental samples.  This proposed method replaces the 
culturing steps on violet red bile glucose agar (VRBGA) and TSA with culturing on 
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chromogenic DFI or ES agar.  For identification and confirmation of presumptive  
E. sakazakii isolates, the oxidase test, yellow pigment production and API biochemical 
profiling is replaced by DNA sequencing and/or species-specific PCR with the most 
accurate primer pair (Esakf and Esakr).  The amendments to the current FDA method 
will reduce the time to detect E. sakazakii from approximately 7 days to 4 days and 
should prove to be more sensitive, specific and accurate for E. sakazakii detection. 
In this study, a novel PCR-based method was developed which was shown to be 
capable of discriminating between viable and dead E. sakazakii cells.  This was 
achieved utilising the irreversible binding of bacterial DNA to photo-activated PMA or 
EMA in order to prevent PCR amplification from the dead cells.  At concentrations of 50 
and 100 µg.ml-1, PMA completely inhibited PCR amplification from dead cells, while 
causing no significant inhibition of the PCR amplification from viable cells.  EMA was 
equally effective in preventing PCR amplification from dead cells, however, it also 
inhibited PCR amplification from viable cells.  PMA-PCR in particular, will be useful for 
assessing the efficacy of processing techniques, as well as for monitoring the 
resistance, survival strategies and stress responses of E. sakazakii.  This will be an 
important step in the efforts to eliminate E. sakazakii from food and food production 
environments. 
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UITTREKSEL 
 
Die Wêreld Gesondheidsorganisasie (WGO) beraam dat ten minste 75% van alle babas 
net baba formule melk (BFM) of BFM in kombinasie met moedersmelk in die eerste vier 
maande na geboorte kry.  Die teenwoordigheid van die voortkomende patogeen 
Enterobacter sakazakii in BFM is al geassosieer met skaars maar noodlottige gevalle 
van neonatale infeksies en sterftes.  Akkurate metodes word dus benodig vir die vinnige 
deteksie van E. sakazakii in voedsel.  Die metodes wat huidiglik gebruik word vir die 
deteksie en identifikasie van hierdie mikroörganisme is onvoldoende, kontroversieël en 
teenstrydig.  Die doel van hierdie studie was om die beste metode vir die deteksie van 
E. sakazakii te bepaal, na 'n evaluasie van die metodes wat huidiglik beskikbaar is.  'n 
Verdere doel was om 'n polimerase ketting reaksie (PKR) metode vir die deteksie van 
slegs lewensvatbare E. sakazakii selle te optimiseer deur gebruik te maak van die DNS-
bindende kleurstowwe, etidium mono-asied (EMA) en propidium mono-asied (PMA).   
 Die Voedsel en Medisyne Administrasie (VMA) se metode vir E. sakazakii deteksie 
is gebruik om, ongeag van die kolonie kleur, 50 isolate vanuit BFM en 14 isolate vanuit 
die omgewing te kies.  Hierdie isolate is geïdentifiseer deur die DNS volgorde van 'n 1.5 
kilo-basis (kb) fragment van die 16S ribosomale DNS (rDNS) te bepaal en die Nationale 
Sentrum vir Biotegnologiese Informasie (NSBI) databasis te gebruik om die mees 
verwante spesie te bevestig.  Sewe van die 50 (14%) BFM isolate en ses van die 14 
(43%) omgewings isolate is geïdentifiseer as E. sakazakii.  Die metodes wat geëvalueer 
is in terme van akkuraatheid vir deteksie en identifikasie van hierdie E. sakazakii isolate 
het PKR met ses verskillende spesie-spesifieke peiler pare soos beskryf in die 
literatuur, geel-pigment produksie op triptoon soja agar (TSA) en chromogeniese 
Druggan-Forsythe-Iversen (DFI) en Enterobacter sakazakii (ES) agars ingesluit.  Die 
geskiktheid van die VMA metode is verlaag deur die lae sensitiwiteit, spesifisiteit en 
akkuraatheid (87%, 71% en 74% onderskeidelik) van geel pigment produksie vir  
E. sakazakii identifikasie.  Chromogeniese DFI en ES agars was sensitief, spesifiek en 
akkuraat (100%, 98% en 98% onderskeidelik) vir die identifikasie van E. sakazakii.  Die 
spesifisiteit van die PKR produkte het gewissel tussen 8% en 92%, en Esakf en Esakr is 
as die akkuraatste geëvalueerde peiler paar geidentifiseer.   
 Die huidige VMA metode vir E. sakazakii deteksie vereis hersiening aangesien 
meer sensitiewe, spesifieke en akkurate deteksiemetodes voortdurend beskikbaar 
word.  'n Nuwe metode, gebaseer op die resultate van hierdie studie, word voorgestel 
vir die deteksie van E. sakazakii in voedsel- en omgewingsmonsters.  Die voorgestelde 
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metode vervang die kwekingsstap op violet rooi gal glukose agar (VRGGA) en TSA 
deur kweking op chromogeniese DFI of ES agars.  Verder word die oksidase toets, geel 
pigment produksie en API biochemiese profiele van vermoeidelike E. sakazakii isolate 
vervang deur DNS volgorde bepaling en/of spesie-spesifieke PKR met die mees 
spesifieke peiler paar (Esakf and Esakf) vir die identifikasie en bevestiging van  
E. sakazakii.  Die voorgestelde wysigings van die VMA metode sal die tydsduur van  
E. sakazakii identifikasie van 7 dae na 4 dae verminder, en behoort ook meer sensitief, 
spesifiek en akkuraat te wees vir die deteksie van E. sakazakii.   
 'n Nuwe PKR-gebaseerde metode wat tussen lewensvatbare en dooie  
E. sakazakii selle kan onderskei is in hierdie studie ontwikkel.  Dit is bereik deur die 
onomkeerbare binding van bakteriële DNS aan lig-geaktiveerde EMA of PMA om die 
PKR amplifisering van dooie selle te voorkom.  Konsentrasies van 50 en 100 µg.ml-1 
PMA het PKR amplifikasie heeltemal geïnhibeer, terwyl geen inhibisie van 
lewensvatbare selle bespeur kon word nie.  EMA was ook suksesvol in die voorkoming 
van die PKR amplifikasie van dooie selle, alhoewel daar ook 'n mate van DNS inhibisie 
was tydens die amplifikasie van lewensvatbare selle.  PMA-PKR kan ook van nut wees 
vir die assessering van die doeltreffendheid van prosesseringstegnieke, en ook vir die 
waarneming van die weerstandigheid, oorlewingsstrategieë en stresresponse van  
E. sakazakii.  Dit sal 'n belangrike stap wees in pogings om E. sakazakii van voedsel en 
voedsel produksieomgewings te elimineer.   
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CHAPTER 1 
 
INTRODUCTION 
 
Microbial foodborne diseases pose a considerable threat to human health and 
have become a growing concern to food legislators, food manufacturers and consumers 
worldwide.  The risks associated with the microbial contamination of foodstuffs are 
increased by the globalisation of the food supply, as well as changes in the health, 
economic status and dietary patterns of the human population (WHO, 2002).  The 
proportion of individuals that are highly susceptible to foodborne diseases is increasing 
due to ageing and HIV-associated infections.  In developing countries, reduced 
immunity caused by malnutrition renders infants and children especially vulnerable to 
foodborne infections (WHO, 2002). 
It is estimated that less than 35% of infants worldwide are exclusively breastfed 
during the first four months of their lives.  Complementary feeding practices are often ill-
timed, nutritionally inadequate and unsafe due to poor hygiene and improper handling 
(WHO, 2001).  Newborns have immature immune systems and sterile gastro-intestinal 
tracts making them highly susceptible to infections (Newburg, 2005).  Therefore, 
products like infant formula milk (IFM) require high levels of microbiological quality 
control during production, distribution and use (Iversen & Forsythe, 2003).  The 
manufacture of sterile IFM is, however, not feasible using the current processing 
technology.  Since product sterility is not mandatory under the prevailing microbiological 
specifications for powdered IFM, commercially available IFM products may occasionally 
contain low levels of pathogens (FAO/WHO, 2004). 
Enterobacter sakazakii is an opportunistic foodborne pathogen, which has 
emerged as a public health concern due to its association with contaminated IFM 
(Iversen & Forsythe, 2003).  The bacterium has been implicated as the cause of life-
threatening cases of meningitis, sepsis and necrotising enterocolitis in infants (Biering et 
al., 1989; Bar-oz et al., 2001; Lai, 2001; Van Acker et al., 2001).  The prognosis of  
E. sakazakii infections is poor, with case mortality rates reported to be between 40 and 
80% (Willis & Robinson, 1988).  The predominant factors predisposing infants to  
E. sakazakii infections include premature birth, low birth weight (less than 2 500 g) and 
suppressed immunity (Bar-oz et al., 2001; Block et al., 2002; WHO, 2002; FAO/WHO, 
2004).  This is a particular problem in developing countries, which often have 
considerably higher proportions of infants that have a low birth weight, or that are born 
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to HIV-positive mothers, than developed countries (FAO/WHO, 2004).  These infants 
are more likely to be susceptible to infections in general and may also specifically 
require IFM due to the risk of mother-to-child HIV transmission through breastfeeding 
(WHO, 2001; FAO/WHO, 2004).   
Since low E. sakazakii numbers (1 cfu.100 g-1) can have a severe impact on 
health, rapid detection of the pathogen has become an important subject in clinical 
research and food safety (Van Acker et al., 2001).  Nevertheless, there are still no 
standardised or official methods for direct isolation and detection of E. sakazakii from 
foods (Nazorowec-White et al., 2003).  The methods presently used for the detection 
and identification of E. sakazakii are inadequate and controversial, with ambiguous 
results being reported with different methods (Iversen et al., 2004; Lehner et al., 2004; 
Lehner et al., 2006; Liu et al., 2006; Hassan et al., 2007).  Inaccurate E. sakazakii 
detection results can have serious consequences for public health and for the food 
industry.  False-negative results can lead to contaminated products being distributed to 
the public, while false-positive results can lead to financial losses for food 
manufacturers due to product rejections and recalls.  
Despite the increased research interest in E. sakazakii, the threats it poses to 
human health are compounded by the lack of knowledge on this pathogen (FAO/WHO, 
2004).  Little is known, for instance, about the ecology, taxonomy, virulence and survival 
characteristics of E. sakazakii.  Furthermore, there is very limited information on the 
prevalence and genetic diversity of this micro-organism in South Africa.   
A comprehensive understanding of E. sakazakii is imperative, given the substantial 
proportion of the South African population that are HIV-positive and immuno-
compromised.  The aim of this study was to evaluate and compare various methods for 
the isolation, detection and identification of E. sakazakii isolates derived from IFM and 
the processing environment.  These included conventional culturing methods, culturing 
on selective chromogenic media, species-specific PCR using six different primer pairs 
described in the literature and 16S ribosomal DNA (rDNA) sequencing.  A further aim 
was to optimise a novel PCR method for the detection of only viable E. sakazakii cells 
utilising the DNA-intercalating dyes ethidium monoazide (EMA) and propidium 
monoazide (PMA).  
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 3 
References 
 
Bar-Oz, B., Preminger, A., Peleg, O., Block, C. & Arad, I. (2001).  Enterobacter 
sakazakii infection in the newborn.  Acta Paediatrica, 90, 356-358. 
Biering, G., Karlsson, S., Clark, N.V.C., Jonsdottir, K.E., Ludvigsson, P. & 
Steingrimsson, O. (1989).  Three cases of neonatal meningitis caused by 
Enterobacter sakazakii in powdered milk.  Journal of Clinical Microbiology, 27, 
2054-2056. 
Block, C., Peleg, O., Minster, N., Bar-Oz, B., Simhon, A., Arad, I. & Shapiro, M. (2002).  
Cluster of neonatal infections in Jerusalem due to unusual biochemical variant of 
Enterobacter sakazakii.  European Journal of Clinical Microbiology and Infectious 
Diseases, 21, 613-616. 
Food and Agriculture Organisation/World Health Organisation (FAO/WHO) (2004). 
Enterobacter sakazakii and other microorganisms in powdered infant formula: 
Meeting Report, MRA series 6.  Geneva, Switzerland.  [www document].  URL 
http://www.who.int/foodsafety/micro/meetings/feb2004/en/.  15 January 2007. 
Hassan, A.H., Akineden, Ö., Kress, C., Estuningsih, S., Schneider, E. & Usleber, E. 
(2007).  Characterization of the gene encoding the 16S rRNA of Enterobacter 
sakazakii and development of a species-specific PCR method.  International 
Journal of Food Microbiology, 116, 214-220. 
Iversen, C. & Forsythe, S. (2003).  Risk profile of Enterobacter sakazakii, an emergent 
pathogen associated with infant milk formula.  Trends in Food Science & 
Technology, 14, 443-454. 
Iversen, C., Druggan, P. & Forsythe, S. (2004).  A selective differential medium for 
Enterobacter sakazakii, a preliminary study.  Journal of Food Microbiology, 96, 
133-139. 
Lai, K.K. (2001).  Enterobacter sakazakii infections among neonates, infants, children, 
and adults: case reports and a review of the literature.  Medicine Baltimore, 80, 
113-122. 
Lehner, A., Tasara, T. & Stephan, R. (2004).  16S rRNA gene based analysis of 
Enterobacter sakazakii strains from different sources and development of a PCR 
assay for identification.  BMC Microbiology, 4, 43-50. 
 
  
Stellenbosch University  http://scholar.sun.ac.za
 4 
Lehner, A., Nitzsche, S., Breeuwer, P., Diep, B., Thelen, K. & Stephan, R. (2006).  
Comparison of two chromogenic media and evaluation of two molecular-based 
identification systems for Enterobacter sakazakii detection.  BMC Microbiology, 6, 
15-23. 
Liu, Y., Gao, Q., Zhang, X., Hou, Y., Yang, J. & Huang, X. (2006).  PCR and 
oligonucleotide array for detection of Enterobacter sakazakii in infant formula. 
Molecular and Cellular Probes, 20, 11-17. 
Nazorowec-White, M., Farber, J.M., Reij, M.W., Cordier, J.L. & Van Schothorst, M. 
(2003).  Enterobacter sakazakii.  In: International Handbook of Foodborne 
Pathogens (edited by M.D. Miliotos & W.J. Bier).  Pp. 407-413.  New York: Marcel 
Dekker. 
Newburg, D.S. (2005).  Innate immunity and human milk.  The Journal of Nutrition, 135, 
1308-1312. 
Van Acker, J., de Smet, F., Muyldermans, G., Bougatef, A., Naessens, A. & Lauwers, S. 
(2001).  Outbreak of necrotizing enterocolitis associated with Enterobacter 
sakazakii in powdered milk formula.  Journal of Clinical Microbiology, 39, 293-297. 
Willis, J. & Robinson, J.E. (1988).  Enterobacter sakazakii meningitis in neonates.  
Pediatric Infectious Disease, 7, 196-199. 
World Health Organisation (WHO) (2001).  Infant and young child nutrition: global 
strategy for infant and young child feeding, EB109/12.  [www document].  URL 
http://www.who.int/gb.pdf_files/WHA54/ea54r2.pdf.  6 August 2007.  
World Health Organisation (WHO) (2002).  Foodborne diseases.  Fact sheet No. 124.  
[www document].  URL http://www.who.int/mediacentre/factsheet/fs124/en/. 14 
July 2007. 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 5 
CHAPTER 2 
 
LITERATURE REVIEW 
 
A. Background 
 
The World Health Organisation (WHO) recommends that infants be exclusively 
breastfed for the first 6 months of life for optimum growth and development, with 
supplementary foods being introduced to complement breast milk until at least 2 years 
of age (FAO/WHO, 2004).  The percentages of infants being exclusively breastfed and 
the stages at which supplementary foods are introduced differ from country to country.  
In Scandinavian countries, 95% of infants are exclusively breastfed at birth and 75% at 
6 months of age.  In other European countries, however, these percentages are less 
than 30% and close to 0% at the same ages (FAO/WHO, 2004).  When a mother 
cannot breastfeed due to physiological reasons, or chooses not to, it is vital that safe 
and nutritionally adequate breast milk substitutes are provided to satisfy the needs of 
the growing infant.  Powdered infant formula milk (IFM) is the most frequently used 
infant formula product.  It is, however, not sterile and can occasionally contain low levels 
of pathogens (INFOSAN, 2005).  
One such foodborne pathogen, Enterobacter sakazakii, has emerged as a public 
health concern due to its association with contaminated powdered IFM (Iversen & 
Forsythe, 2003).  The organism has been associated with sporadic cases or outbreaks 
of neonatal meningitis, necrotizing enterocolitis and sepsis (Urmenyi & Franklin, 1961; 
Bar-oz et al., 2001; Van Acker et al., 2001).  A review of 48 cases of E. sakazakii 
infections occurring since 1961 revealed that at least 25 cases (52%) were linked to 
powdered IFM (FAO/WHO, 2004).  However, considering the limitations of the current 
surveillance systems in most countries, it is likely that there is a significant under-
reporting of E. sakazakii infections (INFOSAN, 2005).   
Enterobacter sakazakii was recently ranked by the International Commission for 
Microbiological Specifications for Foods (ICMSF, 2002) as a ‘severe hazard for 
restricted populations, life threatening or substantial chronic sequelae or long duration’.  
Consequently, it has the same ranking as well recognised foodborne and waterborne 
pathogens such as Listeria monocytogenes, Clostridium botulinum types A and B and 
Cryptosporidium parvum (Iversen & Forsythe, 2003).  The presence of even low 
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numbers of E. sakazakii in IFM and the potential effects of this micro-organism on 
infected infants is a significant worldwide public health concern (FAO/WHO, 2004).   
 
B. The species Enterobacter sakazakii 
 
Enterobacter sakazakii is a Gram-negative, facultative anaerobic, straight rod belonging 
to the genus Enterobacter and family Enterobacteriaceae (Nazarowec-White & Farber, 
1997a).  The cells have dimensions of approximately 3 µm by 1 µm, are non-sporulating 
and are motile by perithrichous flagella (Farmer et al., 1980).  The earliest recorded use 
of the name E. sakazakii was by Farmer et al. (1977) and Brenner et al. (1977), who 
derived the name to honour the Japanese microbiologist Riichi Sakazaki (Gurtler et al., 
2005).  Prior to this, five other names were used, including the “Urmenyi and Franklin 
bacillus”, “yellow coliform”, “yellow Enterobacter”, “pigmented cloacae A organism” and 
most notably “yellow-pigmented Enterobacter cloacae” (Gurtler et al., 2005).  
Enterobacter sakazakii was designated as a new species by Farmer et al. (1980), 
based on differences from E. cloacae in DNA relatedness, yellow pigment production, 
biochemical reactions and antibiotic susceptibility.   
Enterobacter sakazakii can grow over a temperature range of 6° - 47°C, with 
optimum growth occurring at 39°C (Iversen & Forsythe, 2003).  The bacterium has been 
described as moderately acid resistant due to its ability to survive at pH 3.5, but 
generally not below pH 3 (Edelson-Mammel et al., 2006).  Although little information 
exists on its resistance to alkaline conditions, growth at neutral pH values has been 
reported (Kim & Beuchat, 2005).  Enterobacter sakazakii displays remarkable 
resistance to osmotic stress and drying, enabling it to survive in products with a low 
water activity (aw) (Breeuwer et al., 2003).  It has been demonstrated that E. sakazakii 
can persist for up to two years in cans of dehydrated IFM (Edelson-Mammel et al., 
2005). 
When grown on tryptic soy agar (TSA) at 25°C for 48 h, E. sakazakii colonies 
reach a diameter of 2-3 mm, and are typically bright yellow (Farmer et al., 1980).  Yellow 
pigment production is, however, less pronounced at 36°C and is unstable with repeated 
sub-culturing.  Newly isolated strains of E. sakazakii may produce colonies with two 
distinct morphologies (Farmer et al., 1980).  One colony type is dry or mucoid, with 
scalloped edges, and is difficult to pick with an inoculation loop.  The second colony 
type is typically smooth, often exhibiting little pigment production, and is easily removed 
with a loop.  More recently, this differentiation has been described as “matt” or “glossy” 
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(Iversen & Forsythe, 2003).  It is presently not known whether differences in virulence or 
other phenotypic traits exist between these two colony types (Nazorowec-White & 
Farber, 1997a).  On sub-culturing, it has been observed that “matt” colonies may 
spontaneously revert to “glossy” colonies. 
 
Biochemical reactions  
Biochemical differentiation of E. sakazakii is based on the ability of the bacterium to 
ferment sucrose, raffinose, and α-methyl-D-glucoside, but usually not D-sorbitol, 
dulcitol, adonitol or D-arabinol (Farmer & Kelly, 1992).  Of the biochemical traits, the 
inability to ferment D-sorbitol, as well the ability to produce an extracellular 
deoxyribonuclease, were traditionally considered to be the most significant 
differentiating characteristics of E. sakazakii (Farmer et al., 1980).  More recently, 
however, it has been demonstrated that some E. sakazakii strains are able to ferment 
D-sorbitol (Heuvelink et al., 2001). 
After studying the enzymatic profiles of 226 Enterobacter strains (of which 129 
were E. sakazakii), Muytjens et al. (1984) found two major differences between  
E. sakazakii and other related species.  The absence of the enzyme phosphoamidase 
was unique to E. sakazakii and the activity of the α-glucosidase enzyme was 
demonstrated in all E. sakazakii strains, but not in other Enterobacter species.  
Consequently, the activity of α-glucosidase has become a defining characteristic for 
differentiation of E. sakazakii from other species in the Enterobacteriaceae family 
(Iversen et al., 2006a).  This biochemical feature has been used as a selective marker 
in the development of differential chromogenic media (Iversen et al., 2004a), despite the 
recent finding that a small number of other Enterobacteriaceae do test positive for the 
α-glucosidase enzyme (Iversen et al., 2006b). 
 
Phylogeny and typing 
On designation of E. sakazakii as a unique species, Farmer et al. (1980) described 15 
different biogroups based on biochemical profiles, with the wild type biogroup 1 being 
the most common.  However, a new biogroup of E. sakazakii (biogroup 16) has 
subsequently been introduced (Iversen et al., 2006a).  Based on partial 16S ribosomal 
DNA (rDNA) sequence analysis, it was shown that a relationship exists between the 16 
E. sakazakii biogroups and the genotypes of the micro-organism (Iversen et al., 2006a).  
Strains of E. sakazakii form at least four genetically and biochemically distinct clusters 
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and it is generally recognised that the species is genetically diverse and taxonomically 
complex.  
In order to facilitate epidemiologic investigations and to identify vehicles of 
infection, it has been recommended that laboratories type all E. sakazakii isolates 
(Nazarowec-White & Farber, 1999).  Methods that have been used to type these 
isolates include restriction endonuclease analysis (REA), ribotyping, plasmid typing, 
pulsed field gel electrophoresis (PFGE) and the random amplified polymorphic DNA 
(RAPD) technique (Biering et al., 1989; Clark et al., 1990; Nazarowec-White & Farber, 
1999).   
 
C. Sources of Enterobacter sakazakii 
 
Clinical sources 
Krieg and Holt (1984) reported that E. sakazakii is more prevalent in foods and the 
environment than in clinical surroundings.  Nonetheless, the micro-organism has been 
isolated from a range of clinical sources, including blood, cerebrospinal fluid, bone 
marrow, respiratory tracts (sputum, nose and throat), intestinal tracts, eyes, wounds, 
urine and faeces (Table 1).  In the past, neonatal E. sakazakii infections were suspected 
to originate from maternal vaginal contamination during passing of the infant through the 
birth canal.   Since infections have subsequently been found to occur in newborns 
delivered by Caesarean section, this hypothesis seems improbable (Urmenyi & 
Franklin, 1961; Muytjens et al., 1983; Muytjens & Kollee, 1990; Bar-Oz et al., 2001). 
  Apart from being isolated from a physician’s stethoscope (Farmer et al., 1980),  
E. sakazakii was also detected on spoons and on a blender used to prepare IFM in a 
hospital nursery (Bar-Oz et al., 2001; Simmons et al., 1989).  Furthermore, 
epidemiological evidence obtained by pulsed field gel electrophoresis (PFGE) confirmed 
that a contaminated brush used for cleaning infant bottles was the source of three cases 
of infections in 1981 (Smeets et al., 1998).   It appears that E. sakazakii is capable of 
persisting for extended time periods in a clinical environment.  Three isolates which 
were collected in the same hospital over 11 years had indistinguishable ribotype 
patterns and thus appeared to be the identical strain (Nazorowec-White & Farber, 
1999). 
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Table 1  Sources of Enterobacter sakazakii (adapted from Iversen & Forsythe, 2003) 
Source    Details References 
 
Neonates  
& infants 
 
Meningitis 
 
Urmenyi & Franklin (1961), Jøker et al. (1965), Kleiman et al. (1981), 
Muytjens et al. (1983), Arseni et al. (1987), Willis & Robinson (1988), 
Biering et al. (1989), Lecour et al. (1989), Simmons et al. (1989), Clark 
et al. (1990), Muytjens & Kollee (1990), Noriega et al. (1990), 
Gallagher & Ball (1991), Bar-Oz et al. (2001), Lai (2001). 
 Bacteraemia Monroe & Tift (1979), Clark et al. (1990), Bar-Oz et al. (2001). 
 Necrotising enterocolitis Van Acker et al. (2001). 
 Wounds, appendicitis, Reina et al. (1989). 
 conjunctivitis  
Adults Bacteraemia Jimenez & Gimenez (1982), Pribyl et al. (1985), Murray et al. (1990), 
Hawkins et al. (1991), Lai (2001), Dennison & Morris (2002). 
Food & 
Drink 
Infant formula milk 
powder 
Farmer et al. (1980), Postupa & Aldová (1984), Block et al. (2002), 
Biering et al. (1989), Simmons et al. (1989), Muytjens et al. (1988), 
Bar-Oz et al. (2001), Heuvelink et al. (2001), Himelright et al. (2002). 
 Milk powder Postupa & Aldová (1984), Muytjens et al. (1988), Heuvelink et al. 
(2001). 
 Water, pipelines & biofilm Bartolucci et al. (1995), Al-Hadithi & Al-Edani (1995). 
 Water springs Mosso et al. (1994). 
 Rice seed Cottyn et al. (2001). 
 Beer mugs Schindler & Metz (1990). 
 Cured meat Watanabe & Esaki (1994). 
 Fermented bread Gassem (1999). 
 Lettuce Soriano et al. (2001). 
 Tofu No et al. (2002). 
 Sour tea Tamura et al. (1995). 
 Cheese, minced beef, 
sausage, meat, 
vegetables 
Leclercq et al. (2002). 
 
Hospital air 
 
Masaki et al. (2001). 
 
Environ- 
mental Clinical material Tuncer & Ozsan (1988). 
 Factories & houses Kandhai et al. (2004). 
 Preparation equipment 
(blender, spoons) 
Block et al. (2002), Clark et al. (1990), Smeets et al. (1998), Bar-Oz et 
al. (2001). 
 Rats Gakuya et al. (2001). 
 Flies Hamilton et al. (2003), Kuzina et al. (2001). 
 Soil Neelam et al. (1987). 
 Grass silage 
Rhizosphere 
Van Os et al. (1996). 
Emilani et al. (2001). 
 Sediment, wetlands Espeland & Wetzel (2001). 
 Crude oil Assadi & Mathur (1991). 
 Cutting fluids Suliman et al. (1988). 
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Environmental and food sources 
Enterobacter sakazakii, like most other members of the genus Enterobacter, has been 
shown to be ubiquitous in nature (Table 1).  To date, the reservoir and mode of 
transmission of E. sakazakii has not been identified (Nazorowec-White & Farber, 
1997a).  It has been suggested that environmental and plant material is likely to be the 
primary source of E. sakazakii (Mossel & Struijk, 1995).  More specifically, the main 
environmental sources may be soil, water and vegetables, with rodents and flies as 
secondary means of contamination (Iversen & Forsythe, 2003).  Enterobacter sakazakii 
has been isolated from the digestive tract of the Mexican fruit fly, Anastrpha ludens 
(Kuzina et al., 2001) and the stable fly, Stomoxys calcitrans (Hamilton et al., 2003). 
It appears that E. sakazakii is also a common inhabitant of food manufacturing 
facilities and households.  In a survey of nine food factories (milk powder, chocolate, 
cereal, potato flour, spices and pasta) and 16 households, 23% of the factory samples 
and 31% of the household samples tested positive for E. sakazakii (Kandhai et al., 
2004).  It has been reported that E. sakazakii occurs more commonly in the 
manufacturing environment than species of Salmonella (FAO/WHO, 2004). 
Enterobacter sakazakii has been isolated from a wide variety of different food 
products including meat, vegetables, milk-based products, grains and fermented breads 
(Table 1).  On evaluation of a variety of foods for the presence of Enterobacteriaceae, 
2.4% of IFM samples, 10.2% of dried infant foods, 4.1% of milk powders, 3.2% of 
cheese products and 37.8% of the herb and spice samples tested positive for the 
presence of E. sakazakii (Iversen & Forsythye, 2004).  Although studies of this kind 
illustrate the widespread occurrence of this micro-organism in foods, it is only powdered 
IFM that has been epidemiologically linked to outbreaks of E. sakazakii illnesses.   
 
D. Infant formula milk as a source of Enterobacter sakazakii 
 
Manufacture of infant formula milk 
Since the beginning of the 20th century, the production of IFM from cow’s milk has 
shown a steady increase (Nazarowec-White & Farber, 1997a).  Powdered IFM is 
formulated to mimic the nutritional profile of human breast milk rather than cow’s milk 
(Breeuwer et al., 2003).  Since the two differ in composition, various modifications are 
made during processing, including reducing the levels of protein, minerals and fat, while 
increasing the levels of whey protein and carbohydrates in the milk (Nazorowec-White & 
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Farber, 1997b).  In addition, the calcium to phosphorus ratio is increased and vitamins 
are added.   
In most processing facilities, IFM is produced by combining milk with other 
essential ingredients (milk derivatives, carbohydrates, soy protein isolates, vitamins, 
minerals and additives) using either a “wet’” or “dry” blending method (Fig. 1) 
(FAO/WHO, 2004).  The “wet” blending method involves combining all ingredients in a 
liquid phase, heat-treating the liquid, and then spray-drying to achieve a powdered 
product.  In the “dry” blending method all ingredients are individually prepared and heat-
treated prior to being combined in the dry form.  Problems which limit the use of the 
latter method include difficulties in mixing, segregation of ingredients, as well as a 
higher probability of post-processing contamination (Nazarowec-White & Farber, 
1997a,c).  In some processing facilities, a combined “wet” and “dry” method is used, 
where the soluble ingredients are added during the liquid phase, followed by the less 
soluble ingredients being added to the spray-dried powder.  Since in-factory 
contamination most probably occurs at some point between spray drying and 
packaging, the risk of IFM contamination is dependent on the specific factory 
environment rather than solely the manufacturing processes (Gurtler et al., 2005). 
 
Presence of Enterobacter sakazakii in infant formula milk 
Several investigations into outbreaks of E. sakazakii infections occurring in neonatal 
intensive care units have provided both statistical and microbiological evidence that has 
implicated IFM consumption as the cause of infection (Simmons et al., 1989; Van Acker 
et al., 2001; Himelright et al., 2002).  It is generally accepted that E. sakazakii does not 
survive the pasteurisation process applied during IFM manufacture, and that 
contamination probably occurs following heat treatment (Iversen & Forsythe, 2003; 
FAO/WHO, 2004).   Enterobacter sakazakii can gain entrance into powdered IFM by 
two routes (FAO/WHO, 2004) (Fig. 1).  Intrinsic contamination may arise from the 
addition of contaminated ingredients after drying, or from the factory environment 
between drying and packaging.  External contamination, on the other hand, may occur 
during reconstitution and handling, for instance when using poorly cleaned equipment or 
utensils.   
Analyses of commercial powdered IFM products have revealed the prevalence of  
E. sakazakii at varying frequencies (ca. 0-18% of IFM products); but almost always at 
concentrations of ca. 1 cfu.100 g-1 (ICMSF, 2004; Edelson-Mammel et al., 2005).  In 
one of the most notable surveys of powdered IFM products obtained from 35 countries,  
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5. Vitamins added 
6. Spray-dried 
Figure 1  Risk factors in the manufacture and preparation of powdered infant formula milk (IFM) (adapted from Forsythe, 2005). 
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E. sakazakii was isolated at low levels (0.36 cfu.100 g-1) from 14.2% of the 141 samples 
tested (Muytjens et al., 1988).  All of these products, however, met the prevailing Codex 
Alimentarius Commission (CAC) microbiological specifications for coliform counts in 
powdered IFM (less than 3 cfu.g-1) (Van Acker et al., 2001; Muytjens et al., 1988).  
Evaluation of commercial powdered IFM and baby foods available on the South African 
market revealed the presence of E. sakazakii in 18% of the products tested (Witthuhn et 
al., 2006).   
Reconstituted IFM is nutritious, and may allow rapid growth of bacteria when the 
prevailing water activity, the time for growth, and the temperature are favourable (Forsythe, 
2005).  Numerous studies have focused on the conditions promoting survival and growth 
of E. sakazakii in reconstituted IFM.  Minimum growth temperatures of 5° - 8°C have been 
reported for strains of E. sakazakii (Nazarowec-White & Farber 1997c).  Since it has been 
estimated that 20% of household refrigerators are maintained at temperatures above 10°C 
(Daniels, 1991), these refrigerators provide conditions at which the micro-organism may 
grow.  At temperatures of 10°, 21° and 23°C, average doubling times for E. sakazakii in 
reconstituted IFM have been reported to be 4.98 h, 75 min and 40 min, respectively 
(Nazarowec-White & Farber 1997c; Iversen & Forsythe, 2003).  Thus, even low levels of E. 
sakazakii in IFM can pose a health risk given the potential for rapid multiplication of the 
bacterium during the preparation and holding time (FAO/WHO, 2004).  While optimum 
growth of E. sakazakii has been reported to occur at 37° - 43°C (Iversen et al., 2004b), 
Iversen & Forsythe (2003) suggested that growth of the micro-organism at temperatures 
above 47°C is improbable.  Since E. sakazakii does not appear to be particularly 
thermotolerant (Breeuwer et al., 2003), the survival of the bacterium is unlikely if IFM is 
rehydrated with hot water (70°C) prior to consumption.   
 
Regulatory aspects 
Regulations governing the hygienic manufacture and preparation of IFM appear in the 
Recommended International Code of Hygienic Practice for Foods for Infants and Children 
(CAC, 1979).  This code, adopted by the Codex Alimentarius Commission (CAC) in 1979, 
mandates adherence to good manufacturing practices (GMPs) and clear labeling, but 
contains no requirement for IFM to be sterile.  Rather, the current CAC microbiological 
specifications stipulate allowable levels for mesophilic aerobic bacteria, coliforms and 
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salmonellae in powdered IFM.  There is currently no CAC requirement to test specifically 
for E. sakazakii in IFM (FAO/WHO, 2004).  The limit set for coliforms is a minimum of four 
of five control samples with less than 3 coliforms.g-1 and a maximum of one of five control 
samples with more than 3 but less than or equal to 20 coliforms.g-1.  These specifications 
do not provide a sufficient level of safety, as evident by outbreaks caused by IFM 
contaminated with E. sakazakii at levels below this limit (Van Acker et al., 2001).   
In November 2004, a working group formed by the Codex Committee on Food 
Hygiene (CCFH) drafted a revised code of practice for IFM.  To date, however, no 
consensus has been reached by the CAC on the proposed code of practice.  It is expected 
that the CAC will adopt a revised code in 2009, containing standards for 
Enterobacteriaceae and, in specific for E. sakazakii (CAC, 2007).  In addition, the revised 
code is likely to include validated testing methods, ideally including culturing and PCR 
methodologies. In the meantime, the European Union has officially introduced 
microbiological standards for E. sakazakii (negative in 30 x 10 g samples) in powdered IFM 
(EC, 2005).   
 
E. Enterobacter sakazakii infections 
 
History of outbreaks 
The earliest accounts of infections caused by E. sakazakii originated in England in 1958 
(Urmenyi & Franklin, 1961).  Since then, additional cases of infection due to E. sakazakii 
have been reported in countries such as Canada, Belgium, Germany, Greece, Israel, The 
Netherlands, Spain and the United States of America (Iversen & Forsythe, 2003).  At least 
76 neonatal cases of E. sakazakii infection were reported to have occurred worldwide 
between 1958 and 2003 (Iversen & Forsythe, 2003).  However, it is likely that the reported 
numbers underestimate the actual incidence of E. sakazakii infections, since many clinical 
laboratories do not test for E. sakazakii and official reporting systems have not been 
implemented by many countries (Farber, 2004).  There is a lack of information on both the 
contamination of IFM distributed in developing countries, as well as the disease burden 
resulting from consumption of contaminated IFM in these countries (FAO/WHO, 2004). 
More recent reports of outbreaks of E. sakazakii infection have included the death of a 
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premature infant in July 2004 in New Zealand, as well as an outbreak (2 deaths, 4 
diseased individuals and 9 infected individuals) in France between October and 
December of the same year (INFOSAN, 2005).   
 
Characteristics of disease 
Enterobacter sakazakii has been documented to cause sporadic and severe forms of 
meningitis (an acute inflammation of the membranes surrounding the brain and spinal 
chord) and septicemia (a disease caused by bacteria in the blood) in pre-term and full-
term infants (Muytjens & Kollee, 1990; Himelright et al., 2002).  In addition, the micro-
organism has been associated with several cases of necrotising enterocolitis (the most 
common gastro-intestinal disease in newborns), although it has never been established 
as the causative agent (Muytjens et al., 1983; Van Acker et al., 2001).  The 
manifestation of disease caused by E. sakazakii is severe, with mortality rates 
estimated at 40 - 80% and fatalities often occurring within days of infection (Nazorowec-
White & Farber, 1997a).  Enterobacter sakazakii affects the central nervous system 
(Gallagher & Ball, 1991) and survivors often suffer from severe neurological 
impairments, including hydrocephalus, quadriplegia and developmental delay (Lai, 
2001).   
In most cases, E. sakazakii infections are responsive to antibiotic therapy 
(FAO/WHO, 2004), and infections are traditionally treated with ampicillin in combination 
with chloramphenicol or gentamicin (Lai, 2001).  Unfortunately, a number of authors 
have reported that E. sakazakii is becoming increasingly resistant to these antibiotics by 
means of transposable elements, and also to β-lactam antibiotics by the production of  
β-lactamase (Muytjens et al., 1983; Pitout et al., 1997; Lai, 2001). 
 
Risk groups 
Although E. sakazakii has caused illness in all age groups, a review of the reported 
cases of infections reveals that infants (children less than 1 year) appear to be at 
greatest risk (FAO/WHO, 2004) (Table 1).  Within this group, neonates (less than 28 
days), are particularly susceptible to E. sakazakii infections, especially those that are 
premature, low birth weight (less than 2 500 g) or immuno-compromised.  Although only 
a few E. sakazakii infections have been reported in adults (Table 1), those that have 
been documented all involved immuno-compromised individuals (Hawkins et al., 1991; 
Lai, 2001). 
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Human infants are born with an immature immune system and a gastro-intestinal 
tract that is devoid of micro-organisms (Newburg, 2005).  The inability of infants to 
produce an effective immune response makes this group highly susceptible to 
infections.  It has been suggested that infants are more vulnerable to E. sakazakii 
infection than adults because their stomachs, especially when premature, are notably 
less acidic than that of adults (FAO/WHO, 2004).  This makes them less capable of 
naturally combating pathogens, and may allow prolonged survival of E. sakazakii in the 
body.  The 2002 US FoodNet survey estimated that the rate of infant E. sakazakii 
infections is 1 per 100 000, while among low-birth-weight neonates, the rate was 
estimated to be 8.7 per 100 000 (FAO/WHO, 2004).   
Of concern is the considerable threat that E. sakazakii poses to infants of HIV-
positive mothers.  Not only are these infants more likely to be susceptible to infection in 
general, but they may also specifically require IFM instead of breast milk, due to the risk 
of HIV-transmission from mother to child through breast milk (FAO/WHO, 2004).  This is 
problematic in developing countries, which often have considerably higher proportions 
of infants that are low birth weight or of HIV-infected mothers than developed countries.  
These factors increase the demand and consumption of powdered IFM.  The risks are 
further increased in developing countries with high ambient temperatures, especially 
when there is a lack of refrigeration facilities to store rehydrated IFM.  Under such 
circumstances, it is likely that relatively rapid growth of E. sakazakii might occur 
following IFM reconstitution.  According to FAO/WHO (2004), the relative risk of 
ingesting E. sakazakii in reconstituted IFM after 6 h and 10 h at 25°C increases by 30-
fold and 30 0000-fold, respectively. 
 
Pathogenicity and infectious dose 
Enterobacter sakazakii is considered an opportunistic pathogen since it rarely causes 
disease in healthy individuals.  However, little is known at the molecular level about the 
virulence factors involved in the pathogenesis of this micro-organism.  Pagotto et al. 
(2003) evaluated 18 clinical and food isolates of E. sakazakii for enterotoxin production 
using a suckling mousse assay.  Four of the 18 strains tested positive for enterotoxin 
production.  All E. sakazakii strains were lethal to mice when doses of 108 cfu per 
mouse were administered by intraperitoneal injection, while two strains caused death in 
mice when administered orally.  In addition, some E. sakazakii strains were shown to 
produce cytotoxic effects in mice.  It was concluded that differences in virulence may 
exist between E. sakazakii strains, and some strains may be non-pathogenic.  This is in 
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agreement with the reports of Block et al. (2002), who, after studying a small cluster of 
neonatal infections caused by an unusual biochemical variant of E. sakazakii, 
suggested that there may be several different E. sakazakii biotypes capable of causing 
human illness.  The antioxidant activity resulting from the production of bacterial 
pigments is reported to promote virulence in pathogenic bacteria and allow persistence 
in harsh environments (Liu et al., 2005; Clauditz et al., 2006).  Further research is 
required to elucidate the potential relationship between E. sakazakii virulence and 
yellow pigment production (Lehner et al., 2006a). 
In the more than 76 documented cases of E. sakazakii infections, no 
epidemiological evidence was obtained that could provide a value for the infectious 
dose (the amount of agent that must be consumed to produce symptoms of foodborne 
disease).  It has been estimated that 1000 cells is the infectious dose for E. sakazakii, 
since this is approximately the infectious dose of the pathogenic bacteria Escherichia 
coli O157, Neisseria meningitidis, and Listeria monocytogenes (Iversen & Forsythe, 
2003).  The growth rate of E. sakazakii was used to calculate the time required for the 
bacterium to attain an infectious dose (1000 cells) at different temperatures, using an 
initial E. sakazakii concentration of 1 cfu.100 g-1 in contaminated IFM (Muytjens et 
al.,1988; Nazarowec-White & Farber, 1997a,b,c).  According to this simplistic model, 
reconstituted IFM at 8°, 21° and 37°C would require 9 days, 17.9 h and 7 h, respectively 
to achieve this infectious dose.   
 
F. Growth and death characteristics  
 
Thermal tolerance of Enterobacter sakazakii  
The thermal tolerance of E. sakazakii was investigated after the micro-organism was 
isolated from unopened cartons of ultra-heat treated (UHT) milk (Skladal et al., 1993).  
Concerns over whether the micro-organism could survive pasteurisation, coupled with 
the limited information on its survival characteristics, resulted in a number of thermal 
inactivation studies (Table 2).  Nazarowec-White and Farber (1997b) reported that the 
D-values (the time required for a 10-fold reduction in the viable numbers of a micro-
organism at a given temperature) for E. sakazakii in rehydrated IFM at 52° and 60°C 
were 54.8 min and 2.5 min, respectively (Table 2).  Extrapolation of this data to 72°C 
indicated that E. sakazakii is very thermotolerant, and that a 6 – 7 log
 
viable cell reduction 
would require heating at 60°C for 15 – 17 min.   
Stellenbosch University  http://scholar.sun.ac.za
 18 
More recent thermal resistance studies, however, indicated that the thermal 
resistance of E. sakazakii is strain-dependent and that it is not likely to persist after 
pasteurisation (Breeuwer et al., 2003; Edelson-Mammel & Buchanan, 2004; 
Nazarowec-White et al., 1999).  In the thermal tolerance studies carried out by Iversen 
et al. (2004b) in rehydrated powdered IFM, the D-values reported for a capsulated  
E. sakazakii strain were generally lower than those for the type strain (Table 2).  
However, the z-values (the temperature change required to reduce the D-value by one 
log cycle) for the capsulated and type strains were 5.7 and 5.8, respectively.  It was 
calculated that high temperature short time (HTST) pasteurisation (72°C for 15 s) would 
theoretically result in a 21 log reduction of viable E. sakazakii cells (Iversen et al., 
2004b).   In general, a 4 - 7 log reduction of micro-organisms is required for process 
control during pasteurisation.  It is thus accepted that E. sakazakii would not be capable 
of surviving a commercial pasteurisation process and that product contamination 
probably occurs during drying, filling or reconstitution of IFM (Iversen & Forsythe, 2003).   
A submerged vessel method was utilised to evaluate D58-values of 12 strains of  
E. sakazakii in rehydrated IFM (Edelson-Mammel & Buchanan, 2004) (Table 2).  An 
approximate 20-fold divergence in thermal tolerance was demonstrated between the 
least thermally resistant strain and the most thermally resistant strain.  It was suggested 
that E. sakazakii strains can be divided into two distinctive phenotypes based on their 
different thermal resistance characteristics (Edelson-Mammel & Buchanan, 2004).  
Thermal tolerance studies conducted by Breeuwer et al. (2003) produced substantially 
lower D- and z-values (Table 2) than those determined in other studies (Edelson-
Mammel & Buchanan, 2004; Nazarowec-White & Farber, 1997b).  They concluded that 
E. sakazakii is not particularly thermotolerant, and that it is the remarkable osmotic and 
desiccation resistance of the micro-organism that allows its survival in IFM (Breeuwer et 
al., 2003).   
 
Osmotic and desiccation tolerance 
The aw of powdered IFM is ca. 0.2 and E. sakazakii possesses the ability to survive for 
extended periods in such dry conditions (Gurtler et al., 2005).  In fact, E. sakazakii has 
been shown to exhibit greater osmotic and desiccation tolerance than E. coli, species of 
Salmonella and other Enterobacteriaceae (Breeuwer et al., 2003).  
 Bacteria are known to protect themselves from dehydration by a rapid intracellular 
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Table 2  Decimal reduction time (D-value) and z-value for Enterobacter sakazakii in powdered IFM 
D-value (min)         Reference 
52ºC 53ºC    54ºC        56ºC         58ºC         60ºC      62ºC      65ºC  70ºC 
z-value 
  (ºC) 
 
 
54.8 ± 4.70  
 
23.7 ± 2.50 
 
10.3 ± 0.70 
 
4.2 ± 0.60 
    
   2.5 ± 2.00    
  
5.80 
 
Nazarowec-White  
& Farber, 1997ba 
 8.30 6.40 1.10 0.27      3.10 Breeuwer et al., 2003b 
 20.20 7.10   2.40 0.34      3.60  
    0.40       
    0.48       
    0.50      Breeuwer et al.,  
2003 
    0.51      Edelson-Mammel 
& Buchanan, 2004c 
   21.1 ± 2.70 9.9 ± 0.80 4.4 ± 0.4  0.6 ± 0.30   0.07  5.60 Edelson-Mammel 
& Buchanan, 2004d 
  16.4 ± 0.67 5.1 ± 0.30 2.6 ±  0.48 1.1 ± 0.11 0.3 ± 0.12    5.8 ± 0.40 Iversen et al., 2004be 
  11.7 ± 5.80 3.69 ± 0.06 3.8 ± 1.95 1.8 ± 0.82 0.2 ± 0.11    5.7 ± 0.12 Iversen et al., 2004bf 
a  D-values of 10 strains (5 clinical isolates and 5 food isolates). 
b
 D-values for 4 different strains determined in phosphate buffer. 
c
 D-value at 58°C for E. sakazakii ATCC 51329, the least heat resistant strain. 
d
  D-values for E. sakazakii strain 607, the most heat resistant E. sakazakii strain. 
e
 D- and z-values for E. sakazakii type strain. 
f
 D- and z-values for E. sakazakii capsulated strain.
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accumulation of ions (particularly K+) and compatible solutes (such as trehalose, proline 
and glycine betaine). The mechanism involved in the ability of E. sakazakii to resist 
dehydration has been related to the accumulation of trehalose in the cells (Breeuwer et 
al., 2003).  Trehalose is a non-reducing disaccharide of glucose, which may play a 
crucial role in protecting bacteria from dehydration by stabilising proteins and 
phospholipid membranes (Potts 1994; Kempf & Bremer 1998; Welsh & Herbert, 1999).   
The genetic basis of the dry stress resistance of E. sakazakii involves a genome-
wide expression of functionally different gene clusters (Breeuwer et al., 2004).  These 
include four genes belonging to the cyclic AMP receptor protein regulon, six genes 
concerned with the stringent response, seven genes from the heat shock regulon and 
several genes involved in cell wall function and trehalose synthesis.  These 
mechanisms may offer an explanation for the reports demonstrating the persistence of 
E. sakazakii in dehydrated IFM for at least two years (Edelson-Mammel et al., 2005). 
 
Acid tolerance 
Enterobacter sakazakii has been described as a moderately acid resistant enteric 
bacterium (Edelson-Mammel et al., 2006).  The acid resistance of the bacterium is 
similar to salmonellae (Gorden & Small, 1993), but less than the documented acid 
resistant pathogens L. monocytogenes (Buchanan & Golden, 1998) and E. coli 
(Buchanan & Edelson, 1996, 1999).  Acid resistance studies have indicated that  
E. sakazakii could endure exposure to pH 3.5 for more than 5 h (Edelson-Mammel et 
al., 2006).  At pH values below 3, however, its survival was found to be transitory, with 
substantial diversity in acid resistance existing among different strains.   
In food products, E. sakazakii has been shown to grow in tomato (pH 4.4), 
watermelon (pH 5.0) and cantaloupe (pH 6.8) juices incubated at 25°C; however, it did 
not grow in strawberry juice (pH 3.6) or apple juice (pH 3.9) (Kim & Beuchat, 2005).  
Enterobacter sakazakii has also been found to survive in various fermented food 
products.  These include Khamir, a fermented bread with a pH of ca. 3.9, and Sobia, a 
traditional fermented beverage with a pH range between 3.37 and 5.53 (Gassem, 1999, 
2002). 
 
Biofilm formation 
The attachment of bacterial cells to surfaces can be followed by growth, the production 
of exopolysaccharides (EPS), and subsequent biofilm formation (Kim et al., 2006).  
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Biofilms have been described as complex aggregations of cells attached to a surface, or 
to each other, and typically embedded in protective and adhesive polymeric substances 
excreted by the bacteria (Marshall, 1992).  Enterobacter sakazakii has been reported to 
form biofilms on silicon, latex, stainless steel, polycarbonate, glass and polyvinyl 
chloride (PVC) (Iversen et al., 2004b; Lehner et al., 2005).  The formation of biofilms by 
E. sakazakii may promote its persistence on equipment surfaces in factory and food 
preparation areas, as well as on infant feeding bottles and utensils (Kim et al., 2006).  
Levels of E. sakazakii on silicon and latex from infant bottles have been reported to be 
as high as 104 bacteria.cm-2.  Thus ineffective cleaning of bottles and utensils could 
enable the bacterium to accumulate and serve as a source of infection (Forsythe, 2005).   
Biofilm formation by E. sakazakii is enhanced by the production of a novel 
heteropolysaccharide, which comprises of 29 – 32% glucuronic acid, 23 – 30% D-
glucose, 19 – 24% D-galactose, 13 – 22% D-fucose and 0 – 8% D-mannose (Harris & 
Oriel, 1989).  The existence of bacteria within this matrix substantially increases their 
resistance to environmental stresses, detergents and antibiotics (Norwood & Gilmour, 
2000; Frank et al., 2003).  It has been suggested that bacterial capsules formed by 
excretion of the EPS could promote survival of the organism in IFM for up to 24 months 
(Iversen & Forsythe, 2003). 
 
Potential strategies for inactivation of Enterobacter sakazakii 
Evaluation of potential treatments for the inactivation of microbial pathogens in IFM 
requires an understanding of the unique characteristics of vegetative cells in dry 
products (FAO/WHO, 2004).  Very often, bacteria in a dehydrated state demonstrate 
increased heat resistance, and their survival may be enhanced when the aw is very low 
(Edelson-Mammel et al., 2005).  Furthermore, powdered IFM is packaged in an inert 
atmosphere to prevent nutrient oxidation, which may foster the survival of dormant 
bacterial cells.   
 Since powdered IFM is not a sterile product, the inclusion of a lethal step during 
the preparation of powdered IFM, as well as a decrease in the holding time before and 
during feeding, is recommended to reduce the risks of E. sakazakii ingestion 
(FAO/WHO, 2004).  A 4 log cfu.ml-1 reduction in E. sakazakii levels can be achieved by 
using water at 70°C for rehydration of powdered IFM (Edelson-Mammel & Buchanan, 
2004).  This approach may reduce or even eliminate E. sakazakii from reconstituted 
IFM.  The effectiveness of microwave heating has also been assessed as a strategy to 
eliminate potential pathogens from foods.  The mechanism of microbial killing is thought 
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to involve both thermal and non-thermal electromagnetic radiation effects (Najdovski et 
al., 1991).  A greater than 4 log cfu.ml-1 reduction in E. sakazakii cells was 
accomplished by microwaving reconstituted IFM in infant bottles for 85 – 100 s to a 
temperature of 82° – 93°C (Kindle et al., 1996). 
The incorporation of antimicrobials into IFM has been investigated to reduce the 
risks of E. sakazakii infections.  Caprylic acid is a eight-carbon fatty acid that has 
received GRAS (generally recognised as safe) status due to its natural presence in 
breast and bovine milk (Nair et al., 2004).  Monocaprylin, the monoglyceride ester of 
caprylic acid, reduced E. sakazakii levels by more than 5 log cfu.ml-1 when incorporated 
into reconstituted IFM.  However, it was concluded that the effects of monocaprylin on 
the sensory attributes of IFM requires further evaluation.   
The efficacy of probiotic cultures in controlling E. sakazakii growth in rehydrated 
IFM has been evaluated (Lihono et al., 2004).  Enterococcus faecium was found to be 
more inhibitory to E. sakazakii than Lactobacillus acidophilus or Pediococcus 
acidilacticii.  The inhibitory effect on E. sakazakii is thought to be due to the pH 
reduction in IFM resulting from the production of acid by the probiotic micro-organisms 
(Lihono et al., 2004). 
Based on current knowledge, sterilisation of IFM in its powdered form appears to 
be only possible using irradiation.  Unfortunately, due to the high doses required to 
inactivate E. sakazakii in the dry state, the application of this technology seems to be 
limited by the organoleptic deterioration of the product (FAO/WHO, 2004).  Other 
potential technologies for IFM sterilisation, such as ultra-high pressure and magnetic 
fields, are still at an early stage of development and are currently not suitable for dried 
foods.  Further research in this field is a priority, as is the need for a detection method 
which allows quantitative validation of the killing effect. 
 
G. Isolation and identification of E. sakazakii 
 
The United States Food and Drug Administration (FDA, 2002) has a recommended 
method for the isolation and enumeration of E. sakazakii from IFM, which is similar to 
those originally proposed by Muytjens et al. (1988) and Nazarowec-White and Farber 
(1997a,b,c) (Fig. 2).  These methods are all based on a most probable number (MPN) 
approach using a total of 333 g of product (3 x 100 g, 3 x 10 g, 3 x 1 g), followed by a 
series of culturing steps that may take up to seven days to produce results (Oh & Kang, 
2004).  The culturing steps include pre-enrichment, enrichment in Enterobacteriaceae 
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enrichment (EE) broth, and isolation using selective violet red bile glucose agar 
(VRBGA).  These protocols are only selective for Enterobacteriaceae and are not 
specific for E. sakazakii (Iversen & Forsythe, 2003).  Consequently, five presumptive  
E. sakazakii colonies are chosen from VRBGA and are sub-cultured on TSA at 25°C for 
48 – 72 h.  Colonies are then selected for confirmation tests based on yellow pigment 
production, a trait reported to be typical of E. sakazakii (FDA, 2002; Nazarowec- White 
& Farber, 1997c).  The  FDA (2002) protocol was modified by Wyeth Nutrition (Fig. 2) to 
eliminate the MPN format and to test for the presence or absence of E. sakazakii cells, 
with a sensitivity of 0.365 cfu.100 g-1 (Donnelly, 2005). 
Tests used to confirm the identification of E. sakazakii include the oxidase test 
(oxidase negative) and the API 20E biochemical identification system (Iversen & 
Forsythe, 2003).  DNA-based technologies (Anon., 1996; Kandhai et al., 2004) and  
α-glucosidase-activity tests have recently been utilised as additional means of 
confirming the identification of E. sakazakii.  However, these methods have not been 
validated by the international organisations responsible for establishing microbiological 
standards for foods (FAO/WHO, 2004).   
Isolation of E. sakazakii utilising conventional microbiological methods has a 
number of disadvantages.   This approach is time consuming and E. sakazakii may be 
outgrown by other members of the family Enterobacteriaceae during pre-enrichment 
and enrichment.  This results in few E. sakazakii colonies being transferred to VRBGA 
and the reduced probability of selecting the bacterium for growth on TSA (Iversen et al., 
2004a; Iversen & Forsythe, 2004).  Furthermore, VRBGA contains selective and 
differential ingredients (crystal violet and bile salts no. 3) that can prevent resuscitation of 
injured E. sakazakii cells.  Thus these factors might preclude the detection of E. sakazakii 
in powdered IFM and other foods (Gurtler & Beuchat, 2005).  There is a great need for 
more rapid, reliable and specific methods for screening infant foods for E. sakazakii 
contamination (Iversen et al., 2004a). 
 
Phenotypic identification  
Yellow pigment production 
A trait of most E. sakazakii strains is the production of a non-diffusible yellow pigment 
when grown on TSA (FAO/WHO, 2004).  This feature is used in various E. sakazakii 
detection methods to select presumptive-positive colonies for confirmation tests 
(Nazarowec-White & Farber, 1997a,b,c; Muytjens et al., 1988; FDA, 2002).   
Stellenbosch University  http://scholar.sun.ac.za
 24 
 
 
 
 
                                           3 x 1g   3 x 10 g 3 x 100 g 
  
 
 
   1:10 dilution in distilled watera or BPWb, c 
 
    
 
     10 ml into 90 ml EE broth,  
35°Cd or 36°Ca, b, c, 18 - 24 h  
 
 
 
     VRBGA, 35°Cd or 36°Ca, b, c, 18 - 24 h  
          Direct spreading method: 0.1 mla 
    Direct streaking method: loopful (10 µl)a, d 
Direct pour plate (1 ml)b, c 
 
 
 
 
Five characteristic colonies 
 
 
 
 
   TSA, 25°C, 48 - 72h 
 
 
 
 
        Yellow colonies 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3015 ml 
water 
 
Biochemical  
profiles 
 
 
Oxidase 
test 
 
Production of  
α-glucosidase 
 
DNA-based 
 tests 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PR
IM
A
RY
 
IS
O
LA
TI
O
N 
Pre-enrichment 
Enrichment 
Selection 
ID
EN
TI
FI
CA
TI
O
N 
 
Selective medium 
DFI agar, 35°C, 24 he 
 
Confirmation of 
presumptive 
positives 
Figure 2  Procedures for isolation and identification of Enterobacter sakazakii (Adapted from 
Iversen & Forsythe, 2003). aFDA method (FDA, 2002); bMuytjens et al. (1988); 
cNazorowec-White & Farber (1997a,b,c); dWyeth Nutrition Method (Donnelly, 2005); 
eIversen & Forsythe (2004).   
  
 335 g    335 g   335 g     335 g   
  3015 ml 
water 
 3015 ml 
water 
3015 mld 
water 
Stellenbosch University  http://scholar.sun.ac.za
 25 
Farmer et al. (1980) suggested that yellow pigment production should not be used alone 
as a differential criterion for identification of E. sakazakii, since yellow pigment 
production is not completely unique to E. sakazakii.  In fact, this trait is frequently found 
in the closely-related genus Pantoea, which has also been isolated from reconstituted 
IFM (Muytjens et al., 1988; Iversen & Forsythe, 2004).  Identification based on pigment 
production is further hampered by the occurrence of white E. sakazakii strains (Block et 
al., 2002), the occasional transient nature of the trait and the fact that pigment 
production is significantly more pronounced at 25°C than at higher temperatures 
(Farmer et al., 1980). 
 
α-glucosidase activity 
The activity of the enzyme α-glucosidase has formed the basis for the development of 
numerous chromogenic and fluorogenic selective media (Iversen & Forsythe, 2004; 
Iversen et al., 2004a; Oh & Kang, 2004; Iversen et al., 2006b), which are recommended 
to serve as supplementary tests to confirm the identification of E. sakazakii (Fig. 2).  
Druggan-Forsythe-Iversen agar (DFI) is a selective differential chromogenic agar which 
was specifically formulated for selective detection of E. sakazakii in IFM (Iversen et al., 
2004a).  A chromogen, 5-bromo-4-chloro-3-indolyl-α-D glucopyranoside (X-α-Glc), is 
incorporated in the medium to act as a differential agent by indicating α-glucosidase 
activity.  Enterobacter sakazakii hydrolyses X-α-Glc to liberate the aglycone, 5-bromo-4-
chloro-indolol (Iversen et al., 2004a).  This aglycone subsequently dimerises in the 
presence of oxygen to produce the pigment bromo-chloro-indigo, which is detected as 
blue-green colonies on the medium.  In addition to the chromogen, DFI agar also 
contains sodium deoxycholate, a selective agent for Enterobacteriaceae, as well as a 
hydrogen sulphide indicator (sodium thiosulphate and ammonium iron citrate) to 
differentiate weak α-glucosidase, H2S-positive micro-organisms (such as Proteus 
vulgaris) from E. sakazakii (Iversen et al., 2004a).   
Iversen et al. (2004a) compared the sensitivity of DFI agar with that of the current 
FDA method (Fig. 2) using 95 clinical and food isolates.  All of the E. sakazakii strains 
evaluated were reportedly detected on DFI agar two days sooner than when using the 
FDA method.  The specificity of the medium was also evaluated using 148 
Enterobacteriaceae strains, excluding E. sakazakii.  Only 19 strains representing three 
genera (Escherichia, Pantoea and Citrobacter) gave false-positive results on DFI agar, 
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in comparison with 31 of these strains producing false-positives using the FDA method 
(Iversen et al., 2004a).  
A selective fluorogenic medium known as Oh and Kang (OK) agar incorporates a 
fluorogen, 4-methyl-umbelliferyl α-D-glucoside (α-MUG), which serves as an indicator of  
α-glucosidase production by E. sakazakii (Oh & Kang, 2004).  In this medium, bile salts 
no. 3 is the selective agent for enteric bacteria, while sodium thiosulphate and ferric 
citrate differentiate H2S-producing Enterobacteriaceae.  This fluorogen is also present in 
Leuscher, Baird, Donald and Cox (LBDC) agar developed by Leuscher et al. (2004) for 
presumptive detection of E. sakazakii in IFM.  Detection with this medium is based on 
the formation of yellow-pigmented colonies by E. sakazakii that fluoresce under UV light 
when grown on nutrient agar supplemented with α-MUG.  Colonies formed by other 
Enterobacteriaceae and non-Enterobacteriaceae reportedly do not fluoresce under UV 
light, even when the colonies produced are yellow pigmented (Leuscher et al., 2004).   
A major advantage of chromogenic and fluorogenic substrates is that strong, non-
diffusible colours are produced in detection media, and thus even small positive 
colonies are observed in the presence of more abundant competitors (Iversen et al., 
2004a).  Although the use of these media appear beneficial to decrease the time to 
detect presumptive-positive E. sakazakii isolates (Gurtler & Beuchat, 2005), their 
efficiency is lowered by the co-isolation of a small number of other Enterobacteriaceae 
that are also α-glucosidase positive (Iversen et al., 2004c; Lehner et al., 2006b).  
Although these methods seem to be useful for presumptive detection of E. sakazakii, or 
as a supplementary confirmation test (Muytjens, 1985), presumptive colonies produced 
on selective media require further species identification (Lehner et al., 2006b). 
 
Biochemical profiles 
Biochemical profiles are frequently used as a confirmative test for presumptive-positive  
E. sakazakii isolates (Fig. 2) (Nazarowec-White & Farber, 1997a,b,c; Muytjens et al., 
1988; FDA, 2002).  However, contradictory identification results have been reported to 
occur in different biochemical kits for the same bacterial strain (Iversen et al., 2004a,c; 
Drudy et al., 2006).  Iversen et al. (2004a) compared different biochemical kits for 
identification of E. sakazakii, and reported that three strains which were identified as  
E. sakazakii by the API 20E system were identified as Enterobacter cloacae, 
Enterobacter amnigenus and Enterobacter cloacae/gergoviae with the ID32E system.  
Eight strains identified as E. sakazakii with the ID32E kit gave patterns consistent with 
Pantoea species with the API 20E kit (Iversen et al., 2004a).  Further biochemical 
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characterisation is therefore required to determine the traits most strongly associated 
with strains of E. sakazakii.  Furthermore, there is a significant need for improvement in 
the current, mainly phenotypically based, approach for detecting and confirming 
presumptive E. sakazakii isolates (Gurtler et al., 2005). 
 
Molecular identification 
To minimise the health risks associated with E. sakazakii, effective methods must be 
developed to confirm the results obtained with traditional microbiological methods.  
Such methods are required to rapidly and accurately detect and identify E. sakazakii 
isolates in IFM (Liu et al., 2006).  Molecular assays have become well established as 
valuable alternatives to traditional culturing methods, since they offer rapid, sensitive 
and specific identification of micro-organisms from a variety of sources (Malorney et al., 
2003, Lehner et al., 2004).  A number of molecular methods are utilised for rapid 
detection and/or identification of bacteria, most of which are based on the polymerase 
chain reaction (PCR).  These include conventional PCR with species-specific primers, 
real-time PCR, PCR-ELISA and DNA sequencing.  Despite the promise that these 
methods hold for microbial diagnostics, the acceptance of these techniques is hindered 
by the high investment costs and the lack of official standard regulations (Malorney et 
al., 2003). 
 
Species-specific PCR 
Although PCR detection methods are widely used to identify micro-organisms, no 
validated PCR methods exist at present for the identification of E. sakazakii.  The first 
PCR system published for the detection of E. sakazakii was developed by Keyser et al. 
(2003) based on a 16S rDNA sequence.  Lehner et al. (2004) developed and evaluated 
an alternative PCR detection system for E. sakazakii, which was based on the 16S 
rDNA sequences of 13 E. sakazakii strains derived from different origins, as well as the 
type strain.  This PCR system identified E. sakazakii isolates from both of the 
phylogenetically distinct groups within the species, as well as an E. sakazakii strain not 
detected using the Keyser et al. (2003) primers (Lehner et al., 2004). 
Several other PCR assays for the identification of E. sakazakii have recently been 
described.  These assays employ the macromolecular synthesis operon (MMS), the  
α-glucosidase activity gene, the 16S – 23S rDNA internal transcribed spacer (ITS) 
region, or the 16S rDNA as the target sequence (Seo & Brackett, 2005; Lehner et al., 
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2006b; Liu et al., 2006; Hassan et al., 2007).  In addition, a commercial PCR system 
(BAX®, Oxoid) is available for the identification of E. sakazakii (Hassan et al., 2007). 
Unfortunately, it has been demonstrated that some PCR systems are non-specific, 
reacting with several other closely related species (Hassan et al., 2007).  While PCR is 
generally considered more accurate and reliable for bacterial identification than 
traditional culturing methods (Charteris et al., 1997), these methods are highly 
dependant on the sequence of the primers utilised as well as the PCR conditions of the 
assays.  Therefore, it is important that PCR systems be rigorously tested against closely 
related species to ensure that they are specific for the bacterium to be detected 
(Hassan et al., 2007).    
 
H. Improvements in DNA-based diagnostics 
PCR techniques have significantly improved the detection and identification of bacterial 
pathogens (Nogva et al., 2000), and have found increasing application in food hygiene 
and control systems.  Although there are numerous advantages of PCR methodologies, 
such as their specificity and sensitivity (Scheu et al., 1998), the disadvantage of the 
techniques is their inability to differentiate between the DNA derived from viable and 
dead cells (Herman, 1997).  As a result of the relatively long persistence of DNA in the 
environment after cell death, from a few days to three weeks (Josephson et al., 1993; 
Masters et al., 1994), DNA-based detection methods may detect DNA derived from 
viable and dead cells, and thus frequently tend to overestimate the number of viable 
cells present (Nocker et al., 2006).  The tendency of PCR to detect DNA from dead cells 
for long periods after cell death was demonstrated by Allmann et al. (1995).  These 
researchers showed that heat-killed Campylobacter jejuni cells added to raw milk could 
be detected with PCR five weeks after inoculation.  Since dead, viable but non-
culturable, and culturable micro-organisms may be present in a food sample, it is 
necessary to be able to distinguish between these physiological bacterial states (Scheu 
et al., 1998).    
 Fluorescent-staining techniques have been applied for the differential detection of 
viable and dead bacterial cells (Caron et al., 1998) using fluorescence microscopy, 
fluorometery, or flow cytometry.  Differential live/dead staining with fluorescent dyes is 
also the basis for the commercial LIVE/DEAD® BacLight™ viability kit developed by 
Molecular Probes (Eugene, Oregan, USA).  This kit is based on cell membrane 
permeability and differentiation due to dye inclusion or exclusion (Haugland, 1999).  The 
main disadvantage of most fluorescent-staining techniques is that all bacterial species 
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in a sample are differentially stained and no bacterial identification can be made 
(Maukonen et al., 2006).   
  The detection of mRNA using reverse transcriptase PCR has also been used in an 
attempt to selectively detect viable bacterial cells (Novak & Juneja, 2001; Bentsink et 
al., 2002). However, it is difficult to obtain reproducible and accurate viable and dead 
cell counts with mRNA as a target, due to its intrinsic instability (McKillip et al., 1998; 
Sheridan et al., 1998; Norton & Batt, 1999).  In order to exploit the full potential of PCR 
in microbiological diagnostics, there is a great need for a methodology that allows PCR-
discrimination of DNA derived from live and dead cells (Lee & Levin, 2006).   
Recently, a novel technique using DNA-intercalating stains, such as ethidium 
monoazide (EMA) or propidium monoazide (PMA) (Nocker et al., 2006), in combination 
with real-time PCR was reported to successfully distinguish and quantify viable and 
dead cells in complex samples (Nogva et al., 2003; Rudi et al., 2005a; Lee & Levin, 
2006; Nocker & Camper, 2006; Nocker et al., 2006; Wang & Levin, 2006).  The basis for 
differentiation between viable and dead cells relies on cell membrane integrity, since 
live cells with intact membranes are able to exclude DNA-binding dyes that easily 
penetrate the compromised membranes of dead cells.  Thus, EMA or PMA enters 
bacteria with damaged membranes and can be covalently linked to DNA by photo-
activation (Nogva et al., 2003).  It was previously reported that DNA which is covalently 
bound with the intercalating dye cannot be PCR amplified (Nogva et al., 2003; Rudi et 
al., 2005a; Lee & Levin, 2006; Wang & Levin, 2006) and only DNA from viable cells can 
be detected.  In a more recent publication, however, Nocker and Camper (2006), 
showed that EMA and PMA cross-linking actually renders the DNA insoluble; 
subsequently there is a loss of the insoluble DNA with cell debris during genomic DNA 
extraction.  Furthermore, the same study verified that when subjecting a bacterial 
population comprised of both viable and dead cells to this treatment, there is a selective 
removal of DNA from dead cells (Nocker & Camper, 2006).   
This method has been described as an easy-to-use alternative to both microscopic 
and flow cytometric discriminations between viable and dead cells (Nogva et al., 2003; 
Rudi et al., 2005a,b; Wang & Levin, 2006) and has to date been applied to a number of 
pathogenic bacteria including Campylobacter jejuni (Rudi et al., 2005a), Escherichia coli 
0157:H7 (Nogva et al., 2003; Nocker & Camper, 2006, Nocker et al., 2006), Listeria 
monocytogenes (Nogva et al., 2003; Rudi et al., 2005b), Salmonella spp. (Nogva et al., 
2003 ; Nocker & Camper, 2006, Nocker et al., 2006), Staphylococcus aureus (Nocker et 
al., 2006) and Vibrio vulnificus (Wang & Levin, 2006).  
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Conclusions 
 
Newborn infants have immature immune systems and sterile gastro-intestinal tracts, 
which are rapidly colonised by micro-organisms through oral ingestion.  Infants are 
therefore highly susceptible to infections, and food products designed for their 
consumption require high levels of microbiological quality control during production, 
distribution and use.  The implication of powdered IFM as the primary source of the 
opportunistic bacterial pathogen, E. sakazakii, has become a growing concern to 
consumers, food manufacturers and legislators worldwide. Since it has been 
demonstrated that the current manufacturing technology does not allow for the 
production of sterile IFM, effective risk management strategies are required to address 
the presence of E. sakazakii in food products and to prevent contaminated products 
from being distributed. 
The methods currently used for the detection and identification of E. sakazakii in 
IFM are inadequate and controversial. Conventional microbiological methods are based 
on morphological, physiological and biochemical characteristics.  These methods are 
time consuming and they reflect only the portion of the bacterial genome expressed 
under specific cultivation conditions.  Therefore, the conventional methods may 
underestimate the presence of E. sakazakii in IFM.  Molecular methods, which are 
based on the composition of nucleic acids rather than on the products of their 
expression, are considered more reliable for bacterial detection and identification.  To 
date, there are no standardised or official methods for the direct isolation of E. sakazakii 
from foods.  Since low E. sakazakii levels can lead to fatalities, rapid and accurate 
detection, identification and typing methods are urgently required.   
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CHAPTER 3 
 
EVALUATION OF DIFFERENT METHODS FOR THE DETECTION AND 
IDENTIFICATION OF ENTEROBACTER SAKAZAKII ISOLATED FROM SOUTH 
AFRICAN INFANT FORMULA MILKS AND THE PROCESSING ENVIRONMENT 
 
Abstract 
 
Enterobacter sakazakii is an emerging pathogen associated with life-threatening 
neonatal infections resulting from the consumption of contaminated powdered infant 
formula milk (IFM).  Accurate methods are required for rapid detection of this bacterium, 
since even low cell numbers have been reported to cause disease.  The aim of this 
study was to evaluate various E. sakazakii detection methods in order to ascertain the 
most suitable method for detection and identification of this pathogen.  Samples from 
IFM and the environment were evaluated for the presence of E. sakazakii using the 
isolation steps (pre-enrichment, enrichment and selection) described in the Food and 
Drug Administration (FDA) method for E. sakazakii detection.  Sixty-four isolates (50 
from IFM and 14 from the environment) were selected from tryptone soy agar (TSA), 
regardless of colony appearance, and these isolates were identified by 16S ribosomal 
DNA (rDNA) sequencing.  Thereafter, different culture-dependent and culture-
independent methods were evaluated to accurately detect and identify the E. sakazakii 
isolates.  These methods included the assessment of yellow pigment production on 
TSA, typical colonies on chromogenic Druggan-Forsythe-Iversen (DFI) and 
Chromocult® Enterobacter sakazakii (ES) media and polymerase chain reaction (PCR) 
using six different species-specific primer pairs described in the literature.  Identification 
of E. sakazakii using yellow pigment production was demonstrated to have a low 
sensitivity, specificity and accuracy (87%, 71% and 74%, respectively), which lowers the 
suitability of the FDA method.  Chromogenic DFI and ES media were sensitive, specific 
and accurate (100%, 98% and 98%, respectively) for the detection of E. sakazakii.  The 
specificity of the PCR amplifications ranged from 8% to 92%, emphasising the need for 
rigorous primer testing against closely related species.  Of the primers evaluated, 
Esakf/Esakr were most suitable for E. sakazakii detection and identification.  The 
detection limit of Esakf/Esakr was found to be 104 cfu.ml-1.  The current FDA method for 
E. sakazakii detection should be revised in the light of the availability of more sensitive, 
specific and accurate detection methods.  
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Introduction 
 
Enterobacter sakazakii is a Gram-negative, motile, rod-shaped bacterium belonging to 
the genus Enterobacter and family Enterobacteriaceae (Nazorowec-White & Farber, 
1997).  Until its designation as a unique species in 1980, the bacterium was referred to 
as a “yellow-pigmented Enterobacter cloacae” (Farmer et al., 1980).  In recent years,  
E. sakazakii has become increasingly recognised as an emerging opportunistic 
pathogen and cause of infections in premature and immuno-compromised infants.  
Although rare, E. sakazakii infections are often life-threatening, and most frequently 
cause meningitis, sepsis and necrotizing enterocolitis.  The symptoms of infection are 
severe and the prognosis is poor (Biering et al., 1989; Bar-oz et al., 2001; Lai, 2001; 
Van Acker et al., 2001), with case mortality rates varying from 40 to 80% among 
infected infants (Willis & Robinson, 1988).  A growing number of reports have 
epidemiologically implicated powdered IFM as the source and vehicle of E. sakazakii 
infections (Biering et al., 1989; Van Acker et al., 2001; Himelright et al., 2002).  
With the utilisation of the currently available technology, it is not possible to 
manufacture sterile powdered IFM (FAO/WHO, 2004).  Thus, IFM products containing 
low levels of pathogens may occasionally be distributed in spite of them complying with 
the prevailing microbiological standards for powdered IFM.  Analyses of commercial 
powdered IFM products have revealed the prevalence of E. sakazakii in 0 - 18% of the 
products tested, with concentrations almost always being <1 cfu.100 g-1 (Muytjens et al., 
1988; ICMSF, 2004; Iversen & Forsythe, 2004; Witthuhn et al., 2006).  Since even low  
E. sakazakii cell numbers pose a considerable health risk, accurate and sensitive 
methods are required for the rapid detection of this bacterium in foods. 
At present, the methods used for detection and identification of E. sakazakii are 
inadequate and controversial.  There has also been a lack of consistency between 
results obtained with different detection and identification methods (Hassan et al., 2007; 
Lehner et al., 2004; Lehner et al., 2006).  The current FDA detection method makes use 
of a series of culturing steps to isolate E. sakazakii from food matrices.  These culturing 
steps include pre-enrichment, enrichment in Enterobacteriaceae enrichment (EE) broth, 
culturing on violet red bile glucose agar (VRBGA) and sub-culturing onto tryptone soy 
agar (TSA) (FDA, 2002).  The FDA method utilises the production of yellow pigmented 
colonies on TSA as a criterion for the identification of E. sakazakii.  However, yellow 
pigment production is not unique to E. sakazakii and the occurrence of white  
E. sakazakii strains has been documented (Farmer et al., 1980; Block et al., 2002; 
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Iversen et al., 2006).  The need for simplified and selective E. sakazakii detection 
methods has prompted the development of several chromogenic and fluorogenic media, 
which have been reported to be more rapid and selective for E. sakazakii than the FDA 
method (Iversen et al., 2004a). 
Various researchers (Lehner et al., 2004; Witthuhn et al., 2006) have suggested 
that species-specific PCR is a rapid and accurate alternative to traditional 
microbiological techniques for the detection and identification of E. sakazakii.  The 
reliability and accuracy of PCR-based methods are, however, reliant on the primers 
chosen and the temperature cycling conditions utilised.  It has been reported that 
certain PCR systems show a lack of specificity for E. sakazakii detection (Lehner et al., 
2004).  The aim of this study was to evaluate and compare various methods for the 
detection and identification of E. sakazakii isolates derived from IFM products and the 
processing environment.  These included the FDA culturing method, culturing on 
selective chromogenic Druggan-Forsythe-Iversen (DFI) and Chromocult® Enterobacter 
sakazakii (ES) media, species-specific PCR using six different primer pairs described in 
the literature, as well as 16S rDNA sequencing.   
 
Materials and methods 
 
A schematic representation of the methods utilised to isolate and identify E. sakazakii is 
provided in Figure 1.  The figure shows the FDA (2002) method that was used to isolate 
pigmented and non-pigmented colonies on TSA.  The E. sakazakii identification 
methods used in the FDA protocol, as well as the additional E. sakazakii identification 
methods that were evaluated, are depicted (Fig. 1).  
 
Isolation of Enterobacter sakazakii  
A total of 50 IFM samples and 14 environmental samples were evaluated for the 
presence of E. sakazakii and other micro-organisms.  IFM products were obtained from 
an IFM manufacturer in South Africa, and samples were taken from the products 
according to the method described by Donelly (2005).  Twenty cans of IFM were 
sampled at regular intervals per production lot and these cans were divided into four 
subgroups, with five cans per subgroup.  The cans were surface sterilised with 70% 
ethanol (Sigma-Aldrich, Gauteng, South Africa) and were opened under laminar flow.  A 
mass of 67 g from each of the five cans within the subgroups was transferred to a self-
seal bag using a sterile spoon.  This was repeated for all the subgroups in order to 
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obtain four 355 g composites.  Each 335 g composite was added to 3.015 l of sterile 
distilled water (pre-warmed to 45°C) and after mixing it was incubated at 35°C for 18 - 
24 h (Donelly, 2005).  For environmental sampling, a sterile cellulose sponge immersed 
in 10 ml neutralising buffer within a re-sealable polythene pouch (3M Microbiology, 
Minnesota, USA) was used to swab production areas, including floors, walls, 
preparation surfaces and equipment. The sponge swab was replaced in its pouch and 
transported to the laboratory under refrigeration conditions.  
In accordance with the FDA method, a 10 ml aliquot of the pre-enrichment 
suspension or swab sample was added to 90 ml of EE broth (Oxoid, supplied by C.A. 
Milsch, Cape Town, South Africa), followed by incubation at 35°C for 18 – 24 h (FDA, 
2002).  A loopful of the enrichment culture was streaked onto four quadrants of 
duplicate VRBGA (Oxoid) plates and after incubation at 35°C for 18 - 24 h, growth was 
examined.  A total of five colonies were picked from both VRBGA plates, regardless of 
the colony appearance.  When more than five different colonies were observed on 
VRBGA, the colonies most representative of E. sakazakii (opaque purple to pink, 
sometimes with a purple halo and yellow centres) were picked.  The five presumptive 
colonies were streaked onto TSA (Oxoid) and incubated at 25°C for 48 - 72 h.  
Following incubation, both pigmented and non-pigmented colonies on TSA were 
selected for further investigation.   
The cell morphology and purity of all isolates was evaluated by Gram-staining and 
microscopic examination.  For long-term storage, the purified isolates were maintained 
in 20% (v/v) glycerol (Sigma-Aldrich) at -20°C.  The E. sakazakii type strain DSM 4485T 
(ATCC 29544) and E. sakazakii 1039 (Department of Food Science Culture Collection, 
Stellenbosch University), isolated from a food processing environment (Keyser et al., 
2003), were used as positive controls to validate the detection and identification 
methods used.   
   
DNA isolations 
Single colonies from the purified isolates on TSA plates were transferred to 10 ml 
tryptone soy broth (TSB) (Oxoid), and the cells were grown overnight at 25°C.  DNA 
was isolated according to the method described by Wang and Levin (2006).  Cells were 
harvested from 250 µl aliquots by centrifugation (Eppendorf Centrifuge 5415D) at 8000 
g for 5 min.  Cell pellets were re-suspended in 250 µl distilled water.  All samples were 
mixed with 250 µl double-strength TZ (2 x TZ) (Abolmatty et al., 2000), which consisted 
of 4% (v/v) Triton X-100 (Merck) and 5 mg.ml-1 sodium azide (Merck) in 0.1 M Tris–HCl 
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Figure 1  Schematic outline of the methods used to isolate and identify E. sakazakii and 
other micro-organisms from IFM and the processing environment.  The FDA 
method (2002) used to isolate E. sakazakii is shown, as well as the different 
identification methods evaluated to confirm the presumptive E. sakazakii 
isolates.  The solid arrows represent steps forming part of the FDA method, 
while the dashed arrows indicate additional E. sakazakii detection and 
identification methods evaluated. 
          1:10 dilution in distilled water 
 
Confirmation  
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(Fluka, supplied by Sigma-Aldrich) at pH 8.  Sample tubes were heated in a boiling 
waterbath for 10 min to lyse the cells.  Cell debris was pelleted by centrifugation (10 000 
g, 5 min) and 200 µl of crude DNA from each sample was purified using a Micropure-EZ 
column (Millipore, supplied by Microsep, Cape Town, South Africa).  
  
Identification of isolates by 16S rDNA sequencing 
Isolates were identified using DNA sequence data of a 1.5 kilobase (kb) fragment of the 
16S rDNA.  PCR amplification of this fragment was performed using the primers F8  
(5’- CAC GGA TCC AGA CTT TGA TYM TGG CTC AG -3’) and R1512 (5’- GTG AAG 
CTT ACG GYT AGC TTG TTA CGA CTT -3’) (Felske et al., 1997).  The PCR reaction 
mixture (50 µl total volume) contained 2 µl (400 nM) of each primer, 1 µl (5 U) Taq DNA 
polymerase (5 U.µl-1, Super-Therm, supplied by Southern Cross Biotechnologies, Cape 
Town, South Africa), 5 µl 10 X buffer (with MgCl2) (Super-Therm), 2 µl (0.4 mM) dNTPs 
(10 mM, AB gene, supplied by Southern Cross Biotechnologies), 2 µl 99% (v/v) DMSO 
(Merck) and 2 µl DNA template.  Thermal cycling parameters were as follows: initial 
denaturation at 92°C for 3 min; 35 cycles of denaturation at 92°C for 30 s, annealing at 
54°C for 30 s, elongation at 68°C for 60 s and final elongation at 72ºC for 7 min (Felske 
et al., 1997).   
PCR products were purified using Sigma Spin Post-Reaction Purification Columns 
(Sigma-Aldrich) according to the instructions of the manufacturer.  Sequencing of the 
PCR products was carried out at the DNA Sequencing Facility at Stellenbosch 
University using the ABI 3100 Genetic Analyser (Applied Biosystems, Foster City, USA).  
The generated sequences were compared to sequences in the National Centre for 
Biotechnology Information (NCBI) database utilising the BLASTn search option to 
determine the closest recognised relatives (Altschul et al., 1997).   
 
Oxidase test and yellow pigment production 
Oxidase tests were carried out on overnight cultures of the isolates growing on TSA 
(Oxoid).  Oxidase reagent was freshly prepared before testing by adding 1 g N, N, N’,N’-
tetramethyl-p-phenylenediamine.2HCl (Sigma-Aldrich) to 100 ml distilled water.  A 
sterile applicator was used to transfer a small amount of culture to a piece of Whatman 
no. 1 filter paper (Merck, Cape Town, South Africa), which was impregnated with 
oxidase reagent.  Isolates producing a dark purple colour within 10 s of application were 
recorded as oxidase positive, while those giving no colour reaction were recorded as 
oxidase negative.     
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In accordance with the FDA method, the production of yellow pigmented colonies 
was investigated as a means of identifying presumptive positive E. sakazakii colonies.  
All the purified isolates were streaked onto TSA (Oxoid) and incubated at 25°C for 48 - 
72 h (FDA, 2002).  Following incubation, the isolates producing yellow pigmented 
colonies on TSA were recorded in order to assess the suitability of this criterion for  
E. sakazakii identification.  
 
Chromogenic media 
The selective chromogenic media evaluated and compared in this study were DFI agar 
(Iversen & Forsythe, 2004) and Chromocult® ES agar (Merck).  DFI agar (pH 7.3) 
contained sodium deoxycholate (1.0 g.l-1, Sigma-Aldrich), 5-bromo-4-chloro-3-indolyl  
α-D-glucopyranoside (0.1 g.l-1, Glycosynth, Warrington, UK), sodium thiosulphate (1.0 
g.l-1, Sigma-Aldrich) and ammonium iron(III) citrate (1.0 g.l-1, Sigma-Aldrich), dissolved 
in distilled water prior to addition of TSA (40 g.l-1, Oxoid).  Single colonies from the 
incubated TSA plates were streaked onto DFI and ES agar plates, followed by overnight 
incubation at 37°C for the DFI agar and 44°C for the ES agar.  Colonies that were 
entirely blue-green on DFI agar, or entirely turquoise on ES agar, were considered 
positive for E. sakazakii (Iversen & Forsythe, 2004; Iversen et al., 2004a; Manafi & 
Lang, 2005). 
 
PCR detection of Enterobacter sakazakii 
Species-specific PCR for the detection of E. sakazakii was carried out using six 
different primer pairs (Table 1).  The reaction mixtures for each PCR system were 
prepared as shown in Table 2.  PCR amplification was carried out using a Mastercycler 
Personal (Eppendorf, Germany) using the cycling conditions described in the literature 
(Table 1).  PCR amplifications using all six primer pairs were repeated in triplicate on all 
isolates to ensure the accuracy of the results obtained.  All the amplified PCR products 
obtained with the different primers were separated on 1.5% (m/v) agarose gels, 
containing 0.02 µl.ml-1 ethidium bromide, in 0.5 X TBE electrophoresis buffer.  The 
separated PCR fragments were visualised under an ultraviolet light (Vilber Lourmat, 
Marne La Vallee, France).  The isolates were grouped based on the number of positive 
PCR results obtained with the six primer pairs (Table 3). 
For the determination of the PCR detection limits, E. sakazakii (1039) was grown 
overnight in TSB (Oxoid) at 25°C.  A 1 ml aliquot of the overnight cell suspension was  
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Table 1  Species-specific PCR primers evaluated for the detection of Enterobacter sakazakii 
 
Primer 
name 
 
Primer sequence 
(5’ to 3’) 
       Target PCR cycling conditions 
 
Amplicon 
size (bp) 
Reference 
 
Esak2 
Esak3 
 
 
CCCGCATCTCTGCAGGATTCTC 
CTAATACCGCATAACGTCTACG  
 
 
16S rDNA   
16S rDNA   
 
95°C - 2 min; 35 x (95°C - 35 sec, 61°C - 
60 sec, 72°C - 60 sec); 72°C – 10 min. 
 
900 bp 
 
Keyser et al., 2003 
 
Esakf 
Esakr 
 
 
GCTYTGCTGACGAGTVGGCGG 
ATCTCTGCAGGATTCTCTGG 
 
 
16S rDNA   
16S rDNA  
 
94°C - 2 min; 29 x (94°C - 30 sec, 66°C - 
60 sec; 72°C - 90 sec) ; 72°C - 5 min. 
 
 
929 bp 
 
Lehner et al., 2004 
 
EsAgf 
EsAgr 
 
TGAAAGCAATCGACAAGAAG 
ACTCATTACCCCTCCTGATG 
 
Gene responsible for 
α-glucosidase activity  
Gene responsible for  
α-glucosidase activity  
 
94°C - 2 min; 29 x (94°C - 30 sec, 58°C - 
60 sec, 72°C - 90 sec); 72°C - 5 min.   
 
 
1680 bp 
 
Lehner et al., 2006 
 
SG-F 
SG-R 
 
 
GGGTTGTCTGCGAAAGCGAA 
GTCTTCGTGCTGCGAGTTTG 
 
 
ITSa sequence  
ITSa sequence 
 
94°C - 10 min; 30 x (94°C - 30 sec, 57°C - 
60 sec, 72°C - 1 min); 72°C - 5 min.  
 
 
282 bp 
 
Liu et al., 2006 
 
 
SI-F 
SI-R 
 
 
CAGGAGTTGAAGAGGTTTAACT 
GTGCTGCGAGTTTGAGAGACTC 
 
ITSa sequence  
ITSa sequence 
 
94°C - 10 min; 30 x (94 °C - 30 s, 57°C - 
60 sec, 72°C - 1 min); 72°C - 5 min.  
 
 
251 bp 
 
Liu et al., 2006. 
 
Saka-1 
Saka-2b 
 
ACAGGGAGCAGCTTGCTGC 
TCCCGCATCTCTGCAGGA 
 
 
16S rDNA   
16S rDNA   
 
95°C - 4 min; 30 x (95°C - 60 sec, 50°C - 
60 sec, 72°C - 90 sec) ; 72°C - 4 min. 
 
952 bp 
 
Hassan et al., 2007 
aInternal transcriber spacer (ITS) sequence between 16S and 23S rDNA.  
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Table 2 PCR reaction mixtures utilising species-specific primers for the detection of Enterobacter sakazakii  
Primer 
name 
 
Total 
volume 
Primer 1 
 
Primer 2 
 
Taq DNA 
polymerasea 
Reaction 
buffer 
MgCl2 
 
dNTPs d 
 
Dimethyl 
Sulphoxide 
(DMSO) 
DNA 
template KCl Tris-HCl 
Stock solution 
concentration 
 
(10 µM) (10 µM) (5 U.µl-1) (10 X) (25 mM) (10 mM) 99%  (1M) (1M) 
Esak2/ 
Esak3 
25 µl 
 
1.25 µl 
(500 nM) 
 
1.25 µl 
(500 nM) 
 
0.1 µl 
(0.5  U) 
 
2.5 µlb 
 
 
2 µl 
(1.5 mM) 
 
2.5 µl 
(1 mM) 
 
- 
 
2 µl 
 
- 
 
- 
Esakf/ 
Esakr 
50 µl 
1 µl 
(200 nM) 
1 µl 
(200 nM) 
0.70 µl 
(3.5 U) 
5 µlb 
 
3 µl 
(1.5 mM) 
2 µl 
(0.4 mM) 2 µl 4 µl - - 
EsAgf/ 
EsAgr 50 µl 
0.5 µl 
(100 nM) 
0.5 µl 
(100 nM) 
0.4 µl 
(2U) 
5 µlc 
 
 
2 µl 
(0.4 mM) - 4 µl   
SG-F/ 
SG-R 50 µl 
1.25 µl 
(250 nM) 
1.25 µl 
(250 nM) 
0.4 µl 
(2 U) - 
6 µl 
(3 mM) 
4 µl 
(0.8 mM) - 5 µl 
2.5 µl 
(50mM) 
0.5 µl 
(10 mM) 
SI-F/ 
SI-R 50 µl 
1.25 µl 
(250 nM) 
1.25 µl 
(250 nM) 
0.4 µl 
(2 U) - 
6 µl 
(3 mM) 
4 µl 
(0.8 mM) - 5 µl 
2.5 µl 
(50mM) 
0.5 µl 
(10 mM) 
Saka1/ 
Saka2b 
30 µl 
1 µl 
(333 nM) 
1 µl 
(333 nM) 
0.2 µl 
(1U) 
3 µlb 
 
1.8 µl 
(1.5 mM) 
0.6 µl  
(0.2 mM) - 2.5 µl   
aSuper-Therm, supplied by Southern Cross Biotechnologies. 
bMgCl2-free reaction buffer, Super-Therm. 
cReaction buffer containing MgCl2, Super-Therm. 
dAB gene, supplied by Southern Cross Biotechnologies. 50
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centrifuged to harvest the cells and the pellet was re-suspended in 0.85% (m/v) NaCl 
(Merck).  A dilution series (10-1 to 10-9) of the re-suspended cell suspension was prepared 
in 0.85% (m/v) NaCl (Merck).  For enumeration, duplicate spread plates were prepared on 
TSA (Oxoid).  Following incubation of the plates at 25°C for 48 h, the cell numbers  
(cfu.ml-1) of each dilution was calculated.  DNA was extracted from each of the cell 
dilutions as previously described.  PCR amplification was performed on the extracted DNA 
with each of the six primer pairs (Table 1) to determine the minimum number of cells that 
could be detected.   
 
Validating detection and identification methods  
The sensitivity, specificity and accuracy of yellow pigment production, selective 
chromogenic DFI and ES media and different PCR detection methods were determined by 
comparing the identification results obtained with these methods to those obtained with 
16S rDNA sequencing.  Sensitivity was defined as the number of true positives divided by 
the sum of true positives plus false negatives, expressed as a percentage (Table 4) 
(Greenhalgh, 1997). Sensitivity, also called the true positive rate, gives an indication of the 
efficiency of a test in detecting isolates that are truly E. sakazakii.  Specificity was defined 
as the number of true negatives divided by the sum of false positives plus true negatives, 
expressed as a percentage (Table 4).  Specificity, also called the true negative rate, gives 
an indication of the efficiency of a test in correctly excluding isolates that are not  
E. sakazakii (Greenhalgh, 1997).   Accuracy was defined as the number of true positives 
and true negatives as a proportion of all the results (Table 4), and thus shows the 
proportion of all the tests that gave the correct result (Greenhalgh, 1997).    
 
Results and discussion 
 
Isolation and identification of isolates from IFM and the processing environment  
In order to assess the ability of different methods to accurately detect and identify  
E. sakazakii, the methods evaluated in this study were tested on isolates from South 
African IFM and the processing environment.  Members of E. sakazakii and other 
Enterobacteriaceae were isolated using the FDA method, but were selected from TSA 
regardless of colony pigmentation.  After purification, the isolates were identified using 16S 
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rDNA sequencing.  The identification results for a total of 64 isolates (50 from IFM and 14 
from the processing environment) are presented in Table 3.  Based on the 16S rDNA 
sequencing data, 52 of the 64 strains (81%) isolated from IFM and the processing 
environment were identified as species of Enterobacter (Table 3).  Only 13 of the 64 strains 
(20%) were identified as E. sakazakii and this emphasises the need for accurate methods 
to identify E. sakazakii isolates following selection on VRBGA as part of the FDA method. 
The isolates obtained from seven of the 50 IFM products (14%) evaluated in this 
study were confirmed as E. sakazakii by 16S rDNA sequencing (Table 3).  This percentage 
is slightly lower than that reported by Witthuhn et al. (2006), who found that 18% of South 
African IFM and baby food products tested positive for the presence of E. sakazakii.  
However, in one of the most prominent studies on IFM products obtained from 35 
countries, Muytjens et al. (1988) also found 14% of IFM products to be contaminated with 
low levels of E. sakazakii.  It thus appears that the prevalence of E. sakazakii in South 
Africa is similar to that observed worldwide. However, given the considerable proportion of 
immuno-compromised individuals in South Africa, the risks that the pathogen poses in this 
and other developing countries should warrant cause for concern.   
Other Enterobacteriaceae that were identified among the isolates obtained from the 
50 IFM products included seven Pantoea spp. (14%), five Erwinia spp. (10%), five 
Enterobacter hormaechei strains (10%), three Enterobacter cloacae strains (6%), one 
Enterobacter ludwigii strain (2%) and 17 isolates identified as Enterobacter spp. (34%) 
(Table 3).  Non-Enterobacteriaceae that were identified from the 50 IFM products included 
two Pseudomonas spp. (4%), two Stenotrophomonas maltophilia strains (4%) and one 
Acinetobacter species (2%) (Table 3). 
From the 14 isolates obtained from the processing environment, six of these (43%) 
were confirmed to be E. sakazakii by 16S rDNA sequencing (Table 3).  This high 
prevalence of E. sakazakii in the processing environment poses a major risk for 
contamination of IFM products.  This again emphasises the problems posed by the fact 
that the reservoir and route by which the bacterium enters the processing environment 
remains unknown (Nazorowec-White & Farber, 1997).  Other Enterobacteriaceae that were 
identified among the 14 environmental isolates included two E. cloacae strains (14%), one 
Enterobacter helviticus strain (7%), one E. hormaechei strain (7%) and 4 isolates identified 
as Enterobacter spp. (29%) (Table 3).    
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Evaluation of detection and identification methods 
Oxidase test and yellow pigment production 
The FDA method utilises the oxidase test and yellow pigment production on TSA as criteria 
for identification of presumptive E. sakazakii isolates.  However, it has been documented 
that these methods are not sufficiently sensitive and specific to ensure the detection and 
correct identification of E. sakazakii in food and environmental samples (Iversen et al., 
2004a),  Therefore, in this study the suitability of the oxidase test and yellow pigment 
production for E. sakazakii identification was evaluated on the isolates that were randomly 
selected from South African IFM and processing environments and which were identified 
by 16S rDNA sequencing.  
A total of 62 of the 64 isolates obtained from IFM and the processing environment 
produced a negative result to the oxidase test (Table 3).  Since the FDA method is 
intended to specifically isolate members of the oxidase-negative Enterobacteriaceae family 
(Krieg & Holt, 1984; Iversen & Forsythe, 2003), it was expected that the majority of the 
isolates would be oxidase negative.  The two isolates that were found to be oxidase 
positive (F11 and F13) (Table 3) were both identified by 16S rDNA sequencing as 
members of the genus Pseudomonas, which typically give a positive result to the oxidase 
test (Holt et al., 1994).  All other Enterobacteriaceae isolates (including Enterobacter, 
Erwinia and Pantoea) as well as non-Enterobacteriaceae isolates (including Acinetobacter 
and Stenotrophomonas) gave negative oxidase reactions, which was consistent with the 
recognised oxidase status of these micro-organisms (Holt et al., 1994; Mukhopadhyay et 
al., 2003).  For the purposes of isolating and identifying E. sakazakii, the inclusion of the 
oxidase test is useful for eliminating oxidase-positive organisms from further confirmatory 
testing.  In this study, however, only 2 of 64 isolates (3%) would have been eliminated from 
further testing by means of this test (Table 3).  Since the oxidase test does not provide a 
means to differentiate E. sakazakii form other oxidase-negative microbes, a more specific 
method for E. sakazakii identification is required to replace this step in the FDA method.  
Although yellow pigment production is considered to be characteristic of E. sakazakii 
two of the 15 isolates (13%) identified as E. sakazakii by 16S rDNA sequencing did not 
produce yellow-pigmented colonies on TSA after incubation at 25°C (Table 3).  Both of 
these non-pigmented E. sakazakii strains (E01 and E04) (Table 3) were isolated from the 
IFM processing environment.  The fact that these isolates were not yellow pigmented 
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implies that they would not have been selected for further testing using the FDA method, 
and would thus have remained undetected. This percentage of non-pigmented  
E. sakazakii strains (13%) is greater than that reported by Iversen and Forsythe (2007), 
who found that 2% of E. sakazakii strains did not produce yellow-pigmented colonies on 
TSA at 25°C.  These false-negative results when utilising yellow pigment production to 
identify E. sakazakii lowered the sensitivity of the method to 87% (Table 4).     
The production of yellow-pigmented colonies was also not unique to E. sakazakii, as 
15 of the 51 non-E. sakazakii isolates (29%) were found to produce yellow-pigmented 
colonies on TSA at 25°C (F04, F08, F14, F18, F19, F20, F21, F25, F33, F37, F43, F44, 
F45, F46 and E12) (Table 3).  This high number of false-positive results reduced the 
specificity of E. sakazakii identification based on pigment production to 71% (Table 4).  The 
yellow pigment producing non-E. sakazakii isolates included members of the genera 
Acinetobacter and Pantoea, as well as other species of Enterobacter (Table 3).  This 
observation is consistent with previous reports of yellow-pigment production by 
Acinetobacter sp. (Leuscher et al., 2004), Pantoea sp. (Muytjens et al., 1988; Iversen & 
Forsythe, 2004) and Enterobacter agglomerans (Leuscher et al., 2004), which was recently 
renamed Pantoea agglomerans (Brenner & Farmer, 2005).  Members of all of these genera 
have previously been isolated from IFM (Muytjens et al., 1988; Iversen & Forsythe, 2004; 
Leuscher et al., 2004) and could give false-positive based on yellow pigment production.   
The accuracy, or the overall percentage of correct identification results, was 74% 
when utilising yellow pigment production to identify E. sakazakii (Table 4).  Given the 
serious nature of E. sakazakii infections, this method is not sufficiently accurate to identify 
members of E. sakazakii.  However, it has been reported that the production of pigments 
by bacteria promotes their virulence and persistence in harsh environments (Reverchon et 
al., 2002; Liu et al., 2005).  Therefore, it may be of interest to investigate the correlation 
between yellow pigment production and the virulence of different strains of E. sakazakii. 
Although the FDA method includes the utilisation of biochemical profiling for the final 
confirmation of presumptive-positive E. sakazakii isolates, the disadvantages associated 
with these tests have been published in the literature (Iversen et al., 2004a,b; Drudy et al., 
2006).  Since numerous reports have been made of contradictory identification results 
occurring with different biochemical kits for the same bacterial strain (Iversen et al., 2004a; 
Drudy et al., 2006), it was decided that these test methods would not be re-evaluated in 
this study.  Rather, the focus would be on the evaluation of alternative methods that could 
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serve to replace these non-specific methods currently recommended for E. sakazakii 
detection. 
 
Chromogenic media 
Selective chromogenic media have been reported to be more specific for the detection of 
E. sakazakii than the culturing media currently used in the FDA method (Iversen et al., 
2004a).  Isolates were detected and identified as E. sakazakii on the chromogenic media 
based on the production of characteristic blue-green colonies on DFI agar and as turquoise 
colonies on ES agar (Fig. 2).  Both DFI and ES media gave positive results for all 15 
isolates (including the two controls) (DSMZ 4485T, 1039, E01, E02, E03, E04, E05, E06, 
F01, F03, F05, F06, F07, F09, F10) that were identified as E. sakazakii by 16S rDNA 
sequencing (Table 3).  Since no non-characteristic colonies were obtained with these 
media for the isolates identified as E. sakazakii, the sensitivity of both DFI and ES media 
was 100% for the detection of E. sakazakii (Table 4).  This was expected, since it has been 
reported that 100% of E. sakazakii strains test positive for the α-glucosidase enzyme, and 
thus would be able to hydrolyse the chromogen present in these media and produce 
characteristic coloured colonies (Iversen & Forsythe, 2004; Iversen et al., 2004a).   
The occurrence of one false-positive result (E12) (Table 3) from the 64 isolates 
tested, however, marginally reduced the specificity of both ES and DFI media to 98% 
(Table 4).  Although all other non-E. sakazakii isolates produced white or yellow colonies 
on both chromogenic media, E12 produced blue-green colonies on DFI agar and turquoise 
colonies on ES agar.  However, isolate was identified as Enterobacter helviticus by 16S 
rDNA sequencing (Table 3).  Enterobacter helviticus, originally isolated from fruit powder, 
was recently introduced as a novel species (Stephan et al., 2007).  In agreement with the 
results obtained in this study, E. helviticus has been documented to produce yellow-
pigmented colonies on TSA plates, although 16S rDNA sequencing revealed that these 
isolates were clearly distinct from E. sakazakii (Lehner et al., 2006).  Strains of this species 
have also been reported to produce colonies typical of E. sakazakii after incubation on DFI 
agar (Lehner et al., 2006) and ES agar (Stephan et al., 2007).  Therefore, the efficiencyof 
chromogenic media such as DFI agar and ES agar is lowered by the occurrence of other 
species of Enterobacter that demonstrate α-glucosidase activity.  In previous studies it has 
been suggested that some members of the species Pantoea gave false-positive results on 
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Table 3 The results obtained from conventional microbiological and molecular methods for the detection and identification of Enterobacter sakazakii 
  
 
Phenotypic 
identification 
   
Chromogenic   
media 
E. sakazakii  specific PCR primers              DNA sequencinga 
Isolate 
number Source 
Yellow 
pigment 
Oxidase 
   test 
DFI 
agar 
 ES 
agar 
Esakf 
Esakr 
Esak2 
Esak3 
SG-R 
SG-F 
SI-F 
SI-R 
Saka1 
Saka2b 
EsAgF 
EsAgR        Identification 
    % 
Sequence 
similarityb 
NCBI 
Accession      
number 
 
Controls (n = 2) 
DSMZ 
4485T Clinical + -  + + + + + +    + + Enterobacter sakazakii 99% EF088379.1 
1039 Environ + -  + + + + + +    + + Enterobacter sakazakii 98% EF059824.1 
Group 1 (n = 14) 
E01 Environ - - + + + + + +    + + Enterobacter sakazakii 98% EF059831.1 
E02 Environ + - + + + + + +    + + Enterobacter sakazakii 96% AY803190.1 
E03 Environ + - + + + + + +    + + Enterobacter sakazakii 97% EF059856.1 
E04 Environ - - + + + + + +    + + Enterobacter sakazakii 95% EF059847.1 
E05 Environ + - + + + + + +    + + Enterobacter sakazakii 98% AY752939.1 
E06 Environ + - + + + + + +    + + Enterobacter sakazakii 98% EF059831.1 
F01 Food + - + + 
- 
+ + + +    + + Enterobacter sakazakii 90% EF059873.1 
F02 Food - - - - + + + +    + + Enterobacter sp. 96% AY689062.1 
F03 Food + - + + + + + +    + + Enterobacter sakazakii 97% EF059856.1 
F04 Food + - - - + + + +    + +   Uncultured Pantoea sp. 
sEnterobacter 
98% EF072302.1 
F05 Food + - + + + + + +    + + Enterobacter sakazakii 97% EF059829.1 
F06 Food + - + + + + + +    + + Enterobacter sakazakii 97% EF059826.1 
F07 Food + - + + + + + +    + + Enterobacter sakazakii 96% EF059829.1 
F08 Food + - - - + + + +    + + Acinetobacter sp. 97%  EF514909.1 
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Phenotypic 
identification 
   
Chromogenic   
media 
E. sakazakii specific PCR primers 
             DNA sequencinga 
Isolate 
number Source 
Yellow 
pigment 
Oxidase 
   test 
 DFI 
agar 
ES 
agar 
 Esakf 
Esakr 
Esak2    
Esak3 
SG-R 
SG-F 
SI-F 
SI-R 
Saka1 
Saka2b 
EsAgF 
EsAgR     Identification 
     % 
Sequence 
similarityb 
  NCBI 
Accession        
 number 
 
Group 2 (n = 2) 
F09 Food + - + + + - + +       +   + Enterobacter sakazakii 97% AM075208.1 
F10 Food + - + + + - + +       +   + Enterobacter sakazakii 97% AM075208.1 
 
Group 3 (n = 2)        
E07 Environ - - - - - - + +       +   + Enterobacter sp. 98% EF471901.1 
F11 Food - + - - - - + +       +   + Pseudomonas fulva  98% AM184228.1 
 
Group 4 (n = 1)              
F12 Food - - - - + - - +       +    + Enterobacter cloacae     95%  AJ417459.1 
 
Group 5 (n = 2)              
F13 Food - + - - - - + +       -   + Pseudomonas putida     100%  EF204241.1 
F14 Food + - - - - - + +       -   + Pantoea agglomerans     96% AF130953.1 
 
Group 6 (n = 1)              
F15 Food - - - - + - - +       -    + Enterobacter sp.   98%  EF419181.1 
 
Group 7 (n = 13)              
E08 Environ - - - - - - + + -       - Enterobacter cloacae   99%  Y17665.1 
E09 Environ - - - - - - + + -       - Enterobacter cloacae  97%  EF120473.1 
E10 Environ - - - - - - + + -       - Enterobacter sp.   99%  DQ068769.1 
F16 Food - - - - - - + + -       - Enterobacter cloacae    99%  Y17665.1 
F17 Food - - - - - - + + -       - Enterobacter cloacae   99%  EF120473.1 
F18 Food + - - - - - + + -       - Enterobacter sp.    99%  DQ855282.1 
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Phenotypic 
identification 
   
Chromogenic   
media 
E. sakazakii specific PCR primers 
             DNA sequencinga 
Isolate 
number Source 
Yellow 
pigment 
Oxidase 
   test 
 DFI 
agar 
ES 
agar 
Esakf 
Esakr 
Esak2 
Esak3 
SG-R 
SG-F 
SI-F 
SI-R 
Saka1 
Saka2b 
EsAgF 
EsAgR  Identification 
     % 
Sequence 
similarityb 
NCBI 
Accession      
number 
 
F19 Food + - - - - - + +     -    - Enterobacter sp.  99% DQ855282.1 
F20 Food + - - - - - + +     -    - Enterobacter sp.  99% DQ855282.1 
F21 Food + - - - - - + +     -    - Enterobacter sp. 98% AM396909.1 
F22 Food - - - - - - + +     -    - Enterobacter sp.  98% DQ659161.1 
 
F23 
 
Food 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
+ 
 
+ 
 
    - 
 
   - 
 
Enterobacter sp.  
 
98% 
 
DQ659161.1 
F24 Food - - - - - - + +     -    - Enterobacter sp.  97% AM184248.1 
F25 
 
Food + - - - - - + +     -    - Uncultured Pantoea sp.  98% EF072302.1 
Group 8 (n = 25)             
E11 Environ - - - - - - - +     -    - Enterobacter hormaechei  99% EF059890.1 
E12 Environ + - + + - - - +     -    - Enterobacter helviticus  97% DQ273683.1 
F26 Food - - - - - - - +     -    - Enterobacter hormaechei  98% EF210100.1 
F27 Food - - - - - - - +     -    - Enterobacter hormaechei  98% EF210100.1 
F28 Food - - - - - - - +     -    - Enterobacter hormaechei  98% AY995561.1 
F29 Food - - - - - - - +    -    - Enterobacter hormaechei  98% AY995561.1 
F30 Food - - - - - - - +    -   - Enterobacter hormaechei 
subsp. steigerwaltii  
97% AJ853890.1 
F31 Food - - - - - - - +    -   - Enterobacter sp.  98% AM184248.1 
F32 Food - - - - - - - +    -   - Enterobacter sp.  98% AY297788.1 
F33 Food + - - - - - - +    -   - Enterobacter sp.  96% AM184248.1 
F34 Food - - - - - - - +    -   - Enterobacter sp.  98% AM184248.1 
F35 Food - - - - - - - +    -   - Enterobacter sp.  98% AM184248.1 
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Phenotypic 
identification 
   
Chromogenic   
media 
E. sakazakii specific PCR primers 
             DNA sequencinga 
Isolate 
number Source 
Yellow 
pigment 
Oxidase 
   test 
 DFI 
agar 
ES 
agar 
Esakf 
Esakr 
Esak2 
Esak3 
SG-R 
SG-F 
SI-F 
SI-R 
Saka1 
Saka2b 
EsAgF 
EsAgR     Identification 
%  
Sequence 
    similarityb 
NCBI 
Accession       
number 
 
F36 Food - - - - - - - + - - Enterobacter sp.  98% AM184248.1 
F37 Food + - - - - - - + - - Enterobacter sp. 98% AM184248.1 
F38 Food - - - - - - - + - - Enterobacter sp.  97% AM184248.1 
F39 Food - - - - - - - + - - Erwinia sp.  98% AY660693.1 
F40 Food - - - - - - - + - - Erwinia sp.  99% EF088378.1 
F41 Food - - - - - - - + - - Erwinia soli  99% EF540893.1 
F42 Food - - - - - - - + - - Erwinia soli  98% EF540893.1 
F43 Food + - - - - - - + - - Pantoea ananatis  99% DQ133545.1 
F44 Food + - - - - - - + - - Pantoea ananatis  99% DQ133545.1 
F45 Food + - - - - - - + - - Pantoea ananatis  99% DQ133545.1 
F46 Food + - - - - - - + - - Pantoea sp. 97% DQ413253.1 
F47 Food - - - - - - - + - - Stenotrophomonas maltophilia  100% AJ293472.1 
F48 Food - - - - - - - + - - Stenotrophomonas maltophilia  100% AJ293472.1 
Group 9 (n = 4)            
E13 Environ - - - - - - - - - - Enterobacter sp.  98% DQ659161.1 
E14 Environ - - - - - - - - - - Enterobacter sp.  97% AB114268.1  
 
F49 Food - - - - - - - - - - Enterobacter ludwigii  97% AM184235.1 
F50 Food - - - - - - - - - - Erwinia sp. 99% AY660693.1 
aBased on DNA sequencing of a 1.5 kb fragment of the 16S rRNA gene. 
bPercentage similarity of the isolate to the closest relative in the NCBI database. 
Environ - Environmental samples. 
  
59
 
Stellenbosch University  http://scholar.sun.ac.za
 60 
 
 
 
   Table 4 Evaluation of various Enterobacter sakazakii detection methods compared with 16S rDNA  
sequencing results  
 
Detection method 
evaluated 
 
E. sakazakii 
positive 
E. sakazakii 
negative Sensitivity Specificity Accuracy 
 16S rDNA sequencing 15 51    
 
     
 
 
     
Yellow pigment 28 38 87% 71% 74% 
 
     
 
     
DFI agar 16 50 100% 98% 98% 
 
     
ES agar 16 50 100% 98% 98% 
 
     
 
     
Esakf/Esakr 20 46 100% 90% 92% 
 
     
 
     
Esak2/Esak3 16 50 87% 94% 92% 
 
     
 
     
SG-F/SG-R 34 32 100% 63% 71% 
 
     
 
     
SI-F/SI-R 62 4 100% 8% 29% 
 
  
   
 
     
Saka1/saka2b 21 45 100% 88% 91% 
 
     
 
     
EsAgf/EsAgr 24 42 100% 82% 86% 
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Figure 2 Detection and identification of E. sakazakii with selective chromogenic DFI and 
ES media:  A - blue-green colonies typical of E. sakazakii on DFI agar; B - 
white colonies non-typical of E. sakazakii on DFI agar; C - turquoise colonies 
typical of E. sakazakii on ES agar; and D - white colonies non-typical of  
E. sakazakii on ES agar.  
 
 
A B 
C D 
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DFI agar (Iversen et al., 2004a).  In this study, however, all Pantoea species produced 
non-typical colonies on both DFI and ES media and thus were correctly identified as non- 
E. sakazakii strains. 
The accuracy of both DFI agar and ES agar was 98% for the detection of E. 
sakazakii.  The accuracy of the chromogenic media for detection and identification of E. 
sakazakii surpassed the accuracy of all other detection methods evaluated in this study.  
Thus, the growth of colonies characteristic of E. sakazakii on either DFI agar or ES agar 
appears to be the most suitable method for the detection and identification of E. sakazakii.  
However, due to the fact that these media were not 100% accurate, and that other 
researchers have reported slightly lower specificity results with chromogenic media 
(Iversen et al., 2004a; Lehner et al., 2006), it is recommended that these media are not 
used as the only means of identifying E. sakazakii.  
 
Species-specific PCR 
 
All six of the species-specific PCR systems evaluated in this study were demonstrated to 
be highly sensitive, but the specificity of the systems varied greatly (Table 4).  Table 3, in 
which isolates are grouped according to the number of positive PCR results, clearly shows 
the inconsistencies that existed between the results obtained with different species-specific 
primer pairs.  In comparison to 13 of the 64 isolates being identified as E. sakazakii by 16S 
rDNA sequencing, PCR detected 16 (Esak2/Esak3), 20 (Esakf/Esakr), 21 (Saka1/Saka2b), 
24 (EsAgf/EsAgr), 34 (SG-F/SG-R) and 62 (SI-F/SI-R) of the 64 isolates as E. sakazakii 
(Table 3).  The variation in the results obtained with the different primer pairs indicate that 
some of the primers cited in the literature are neither specific, nor suitable for E. sakazakii 
detection and identification.  
With the exception of the primer pair Esak2/Esak3 (Keyser et al., 2003), which 
demonstrated 87% sensitivity for the detection of E. sakazakii, all the other primer pairs 
evaluated (Esakf/Esakr, SG-F/SG-R, SI-F/SI-R, Saka1/Saka2b and EsAgf/EsAgr) had a 
sensitivity of 100%.  The latter five primer pairs detected all of the 15 E. sakazakii isolates 
(including the two controls) (Table 3). The sensitivity of the primer pair Esak2/Esak3 (87%) 
(Table 4) was lowered due to the failure of these primers to produce positive detection 
results for two (F09 and F10) of the 15 E. sakazakii isolates (Table 3).  F09 and F10 were 
isolated from IFM powder, and were both confirmed to be E. sakazakii (97% DNA 
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sequence similarity, NCBI accession number AM075208.1).  The lack of sensitivity of the 
primers Esak2/Esak3 has previously been described by Lehner et al. (2004), who reported 
that they failed to detect one of 48 target E. sakazakii strains (ATCC 51329).  This PCR 
system was the first published PCR system for detection of E. sakazakii and was based on 
the single E. sakazakii 16S rRNA gene sequence that was available in the NCBI database 
at the time.  Since the development of Esak2/Esak3, a number of additional E. sakazakii 
16S rRNA gene sequences have been added to the NCBI database, and it has been 
demonstrated that E. sakazakii is a diverse and genetically complex species.   
Despite the fact that Esak2/Esak3 had the lowest sensitivity of the primers evaluated, 
this pair was demonstrated to be the most specific for E. sakazakii detection (94%) (Table 
4).  This indicates that, of the six E. sakazakii primer pairs evaluated, Esak2/Esak3 
produced the lowest number of false-positive results.  The three isolates that were 
incorrectly identified as E. sakazakii with Esak2/Esak3 (F02, F04 and F08) (Table 3) were 
most closely related to an Enterobacter sp. (NCBI Accession number AY689062.1), an 
uncultured Pantoea sp. (NCBI Accession number EF514909.1) and an Acinetobacter sp. 
(NCBI Accession number EF072302.1), respectively.   
The species-specific primers Esakf/Esakr was shown to be 90% specific for  
E. sakazakii detection (Table 4).  These primers produced false-positive results for five of 
the food isolates (F02, F04, F08, F12 and F15) (Table 3), which were confirmed to be most 
closely related to an Enterobacter sp. (NCBI Accession number AY689062.1), an 
uncultured Pantoea sp. (NCBI Accession number EF514909.1), an Acinetobacter sp. 
(NCBI Accession number EF072302.1), Enterobacter cloacae (NCBI Accession number 
AJ417459.1) and an Enterobacter sp. (NCBI Accession number EF419181.1), 
respectively. 
The two species-specific primer pairs Saka1/Saka2b and EsAgf/EsAgr, were 88% 
and 82% specific for E. sakazakii, respectively (Table 4).  Both primer pairs produced 
false-positive results for the isolates F02, F04, F08, E07, F11 and F12 (Table 3), which 
were identified as being most similar to an Enterobacter sp. (NCBI Accession number 
AY689062.1), an uncultured Pantoea sp. (NCBI Accession number EF514909.1), an 
Acinetobacter sp. (NCBI Accession number EF072302.1), an Enterobacter sp. (NCBI 
Accession number EF471901.1), Pseudomonas fulva (NCBI Accession number 
AM184228.1) and Enterobacter cloacae (NCBI Accession number AJ417459.1), 
respectively.  In addition, the primer pair  EsAgf/EsAgr gave false-positive results for the 
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isolates F13, F14 and F15 (Table 3), which were identified as being most similar to 
Pseudomonas fulva (NCBI Accession number EF204241.1), Pantoea agglomerans (NCBI 
Accession number AF130953.1) and an Enterobacter sp. (NCBI Accession number 
EF419181.1). 
The species-specific primer pairs SG-F/SG-R and SI-F/SI-R showed the lowest 
specificity (63% and 8%, respectively) of the six primer pairs evaluated for the detection of 
E. sakazakii (Table 4).  The primers SG-F/SG-R were most prone to producing false-
positive results for members of the genera Enterobacter, Pseudomonas and Pantoea 
(Table 3).  The primers SI-F/SI-R produced false-positive results for 47 of the 51 (92%) 
non-E. sakazakii isolates (Table 3).  Both SG-F/SG-R and SI-F/SI-R were designed based 
on the sequencing and alignment of the 16S–23S rDNA internal transcribed spacer (ITS) 
of E. sakazakii (Liu et al., 2006).  After evaluation on 23 E. sakazakii strains and 65 non- 
E. sakazakii strains, these primers were reported to be specific for the E. sakazakii 
detection.  In this study, however, SG-F/SG-R and SI-F/SI-R were shown to be unsuitable 
for the specific detection of E. sakazakii due to the lack of specificity demonstrated by both 
of these primer pairs.  
Overall, the two primer pairs that were established to be the most accurate for the 
detection of E. sakazakii were Esak2/Esak3 and Esakf/Esakr.  Although both primer pairs 
demonstrated 90% accuracy (Table 4) for E. sakazakii detection, Esak2/Esak3 was more 
specific for E. sakazakii (94% specificity) than Esakf/Esakr (90% specificity) (Table 3).  
However, Esakf/Esakr was more sensitive for E. sakazakii detection (100% sensitivity) 
than Esak2/Esak3 (87% sensitivity) (Table 4).  Due to the severe health threats that even 
low E. sakazakii cell concentrations pose to vulnerable individuals, it is imperative that 
detection methods for E. sakazakii do not produce false-negative results (indicated by a 
low sensitivity).  There is a risk that if E. sakazakii remains undetected in IFM products due 
to the low sensitivity of a detection method, that the contaminated product may be 
distributed and consumed.  For this reason, it is proposed that the primer pair Esakf/Esakr 
is more suitable for E. sakazakii detection than Esak2/Esak3. 
Since foodborne pathogens such as E. sakazakii are often present in food products at 
low cell numbers, it is important that the systems designed for the isolation and 
identification of these pathogens have the lowest possible detection limits.  The primer pair 
SI-F/SI-R had the lowest detection limit of the six primer pairs evaluated, giving positive 
results for cell concentrations as low as 10 cfu.ml-1.  However, given the low specificity of 
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this primer set, as well as the fact that this detection limit was considerably lower than the 
detection limit of 103 cfu.ml-1 normally associated with PCR systems (Olsen et al., 1995), 
these results were suspected  to be invalid.  The detection limits of Esakf/Esakr and 
Esak2/Esak3, the two primer pairs demonstrated to be the most accurate for E. sakazakii 
detection, were 104 cfu.ml-1 and 106 cfu.ml-1, respectively.  The lower detection limit of 
Esakf/Esakr supports the former consensus that that this primer pair is more suitable for  
E. sakazakii detection than Esak2/Esak3.  The detection limits of the primer pairs SG-
F/SG-R, Saka1/Saka2b and EsAgf/EsAgr were found to be 106 cfu.ml-1, 104 cfu.ml-1, and 
102 cfu.ml-1, respectively.  However, given that these primers were demonstrated to be 
less accurate than Esakf/Esakr, the latter primers were considered to be more suitable for  
E. sakazakii detection than the former primers. 
 
Conclusions 
 
The results of this study indicated inconsistencies between the results obtained using 
different E. sakazakii detection methods.  The current FDA method for E. sakazakii 
detection not only proved to be a lengthy procedure, but this method was not sufficiently 
accurate to ensure the detection and correct identification of E. sakazakii.  The use of the 
oxidase test to eliminate oxidase positive micro-organisms was time consuming and labour 
intensive, and this method had little bearing on identifying the potential pathogens.  
Furthermore, the sensitivity, specificity and accuracy of the FDA method were 
demonstrated to be lowered by the use of yellow pigment production as an identification 
criterion for E. sakazakii.  The current FDA method thus needs to be revised and 
alternative identification methods need to be incorporated that allow more rapid and 
specific detection of E. sakazakii.   
In this study, DFI and ES agar were identified as highly sensitive, specific and 
accurate means for detecting and identifying E. sakazakii isolated from both food and 
environmental samples.  These media could be used as a first-step approach for detecting 
E. sakazakii colonies after enrichment.  The large degree of variation in the specificity of 
the PCR primers evaluated emphasised the need for PCR applications to be rigorously 
tested against closely related species to validate the methods.  Based on the results of this 
study, Esakf/Esakr were the most suitable for E. sakazakii detection and identification, with 
an overall accuracy of 92%.  rDNA sequencing and/or the use of species-specific PCR 
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with Esakf/Esakr would prove useful as a means of confirming the identification of 
presumptive E. sakazakii colonies obtained on DFI and ES media.  Overall, it was 
demonstrated that selective chromogenic media, as well as molecular methods such as 
DNA sequencing and PCR, should have an important place in methods recommended for 
the detection and identification of E. sakazakii. 
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CHAPTER 4 
 
NOVEL PCR DETECTION OF VIABLE ENTEROBACTER SAKAZAKII CELLS 
UTILISING PROPIDIUM MONOAZIDE AND ETHIDIUM BROMIDE MONOAZIDE 
 
Abstract 
 
Due to the persistence of DNA in the environment after bacterial cell death, DNA-based 
detection methods such as the polymerase chain reaction (PCR) are unable to distinguish 
between positive PCR signals arising from viable and dead bacterial targets.  In order to 
ensure that PCR detection systems for foodborne pathogens are reliable, the 
discrimination between viable and dead bacteria is crucial.  The detection of the emerging 
pathogen Enterobacter sakazakii is important due to its association with sporadic 
outbreaks of life-threatening infections, especially in low-birth weight, immuno-
compromised infants.  The aim of this study was to optimise a method to selectively detect 
only viable E. sakazakii cells in the presence of dead cells, utilising the DNA-intercalating 
dyes propidium monoazide (PMA) or ethidium bromide monazide (EMA) in combination 
with PCR.  With this method, the basis for differentiation between viable and dead cells 
relies on the ability of these dyes to penetrate the compromised membranes of dead cells, 
while being unable to penetrate the intact membranes of viable cells.  On penetration of 
the dead cells, EMA and PMA can be covalently linked to the bacterial DNA by photo-
activation, resulting in the prevention of DNA amplification during the subsequent PCR 
reaction.  At concentrations of 50 and 100 µg.ml-1, PMA completely inhibited DNA 
amplification from dead cells, while causing no significant inhibition of the amplification 
from viable cells.  PMA was also shown to be effective in allowing selective PCR detection 
of only viable cells in mixtures of varying ratios of viable and dead cells.  EMA was equally 
effective in preventing amplification from dead cells, however, it also inhibited DNA 
amplification from viable cells.  This study demonstrated the efficiency of PMA for 
viable/dead differentiation of E. sakazakii, as well as the lack of selectivity of EMA for this 
purpose.  The PMA-PCR, in particular, will be useful for monitoring the resistance, survival 
strategies and stress responses of E. sakazakii in foods and the environment.   
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Introduction 
 
The accurate detection of the emerging pathogen Enterobacter sakazakii is of importance 
to public health, due to its association with sporadic outbreaks of sepsis, meningitis and 
necrotising enterocolitis (Nazarowec-White & Farber 1997; Bar-Oz et al., 2001; van Acker 
et al., 2001).  Of particular concern is that the population groups that are at the highest risk 
from E. sakazakii infections are low-birth weight or immuno-compromised neonates and 
infants (Forsythe, 2005), who are so susceptible to infections that even low concentrations 
of this bacterium may cause fatalities (Liu et al., 2006).  Enterobacter sakazakii has been 
detected in various food products and food production facilities (Postupa & Aldová, 1984; 
Soriano et al., 2001; Kandhai et al., 2004).  However, to date, powdered infant formula milk 
(IFM) is the only food that has been epidemiologically linked to outbreaks of disease.   
Since the discovery of the polymerase chain reaction (PCR) (Mullis et al., 1986; 
Mullis & Faloona, 1987), there has been a progressive increase in the application of the 
technique for the detection of specific bacterial pathogens within mixed microbial 
populations (Nogva et al., 2000).  The attractiveness of PCR-based techniques includes 
their enhanced specificity and sensitivity over traditional culture techniques, as well as their 
ability to obtain results more rapidly (Olsen et al., 1995).  In spite of these advantages, the 
major disadvantage of conventional PCR is that it does not provide information related to 
the viability of the detected bacteria.  In fact, the DNA derived from cells destroyed by heat, 
disinfectants and antibiotics may serve as a template for PCR amplification for many days 
following the loss of viability (Chaiyanan et al., 2001; Nogva et al., 2003; Rudi et al., 2005).  
The possibility of false-positive PCR results limits the application of PCR for 
microbiological monitoring of foods (Wang & Levin, 2006).   
Most food decontamination and preservation treatments are aimed at complete 
removal or inactivation of potential pathogens (Bolder, 1997).  Since conventional PCR-
based methodologies are not suitable for bacterial viability assessment, they cannot be 
used to assess the effectiveness of inactivation techniques.  To circumvent this, a novel 
alternative has recently been developed, which allows selective detection of only viable 
bacteria in a sample. The novelty of the method lies in the use of specific DNA-
intercalating dyes, capable of selectively modifying the DNA present in dead cells upon 
penetration through their compromised cell membranes.  Since the dyes are unable to 
penetrate the intact membranes of viable cells, they cannot intercalate with the DNA from 
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these cells.  Consequently, only DNA from viable cells is PCR-amplified and detected 
(Nogva et al., 2003).  Although selective analysis of DNA from viable cells was first 
described by Nogva et al. (2003) for ethidium bromide monoazide (EMA), Nocker et al. 
(2006) recently reported a similar technique using propidium monoazide (PMA) as the 
DNA-intercalating dye.  The aim of this study was to optimise and compare the PMA-PCR 
and EMA-PCR methods for selective detection of viable E. sakazakii cells in the presence 
of dead cells.   
 
Materials and methods 
 
Strain and culture conditions  
Enterobacter sakazakii (1039, Department of Food Science Culture Collection, 
Stellenbosch University) was isolated from a food processing environment (Keyser et al., 
2003).  The strain was stored in 20% (v/v) glycerol (Sigma-Aldrich, Gauteng, South Africa) 
at -20°C prior to use.  It was subsequently streaked onto tryptone soy agar (TSA) (Oxoid, 
supplied by C.A. Milsch, Cape Town, South Africa) and was incubated at 25°C for 24 h.  
Single colonies from the TSA plates were transferred to 10 ml tryptone soy broth (TSB) 
(Oxoid), and the cells were grown overnight at 25°C.  The purity of the strain was 
confirmed after Gram-staining and microscopic examination. 
Enterobacter sakazakii cell concentrations were determined spectrophotometrically.  
A 1 ml aliquot of the overnight cell suspension was centrifuged to harvest the cells and the 
pellet was re-suspended in 1.5% (m/v) NaCl (Merck, Cape Town, South Africa) (Wang & 
Levin, 2006).  A dilution series (10-1 to 10-8) of the re-suspended cell suspension was 
prepared in 1.5% (m/v) NaCl (Merck), and the optical density of each dilution was 
determined with a spectrophotometer (Beckman Coulter DU530, Beckman Instruments, 
Fullerton, USA) at 600 nm.  Duplicate spread plates were prepared from the dilutions (10-1 
to 10-8) on TSA, followed by incubation at 25°C for 48 h.  A standard curve was 
constructed of the cell counts (cfu.ml-1) against the corresponding optical density values.  
     
Conditions causing cell death 
Two strategies were followed to kill cells prior to PMA- or EMA-PCR.  Tubes containing 
250 µl of a 107 cfu.ml-1 cell suspension were heated at 100°C in a waterbath for 5 min and 
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then placed on ice.  Alternatively, 250 µl aliquots of a 107 cfu.ml-1 cell suspension were 
centrifuged and the cells were re-suspended in 70% (v/v) isopropanol (Merck) for 10 min 
(Nocker & Camper, 2006).  The isopropanol was removed by harvesting the cells by 
centrifugation prior to re-suspension in 250 µl 1.5% (m/v) NaCl (Merck).  The absence of 
viable cells was confirmed by spread plating 100 µl aliquots of heat- or isopropanol-treated 
cells on TSA plates as described.    
 
Optimisation of PMA and EMA treatments  
PMA (Biotium, Inc., California, USA) or EMA (Sigma-Aldrich) was added at final 
concentrations of 100, 50 or 10 µg.ml-1 to sample tubes containing 250 µl of either viable, 
heat-killed or isopropanol-killed cells (all derived from a 107 cfu.ml-1 cell suspension).  
Samples were incubated in the dark for 5 min to allow penetration of PMA or EMA into 
dead cells.  Photo-induced cross-linking of PMA and EMA was achieved by exposing the 
samples for 1 min to a 750 W halogen light bulb (Osram, supplied by Starlight Electrical, 
Cape Town, South Africa), positioned 20 cm from the sample tubes.  Sample tubes were 
placed on ice to avoid excessive heating.  Each sample treatment was repeated in 
triplicate to ensure the reproducibility of the results.  Control samples used in the study 
were 250 µl of viable, heat- and isopropanol-killed cells (all derived from a 107 cfu.ml-1 cell 
suspension) that were not exposed to treatment with PMA or EMA.  
 
Mixtures of viable and dead cells 
In order to determine the effectiveness of PMA and EMA in selectively allowing DNA 
amplification from viable cells when in the presence of dead cells, mixtures of viable and 
dead cells were evaluated.  Following the heat-killing of a 107 cfu.ml-1 suspension of  
E. sakazakii as described, the dead cells were mixed with viable cells (107 cfu.ml-1) in 
defined ratios.  Mixtures were prepared such that viable cells represented 0, 25, 50, 75 or 
100% of the total bacterial cell concentration.  PMA and EMA treatments were carried out 
in triplicate on 250 µl of the cell mixtures using 100 µg.ml-1 PMA or EMA, 5 min penetration 
in the dark and 1 min light exposure.  As controls, mixtures containing viable cells at 0, 25, 
50, 75 or 100% of the total bacterial cell concentration were utilised without any PMA or 
EMA treatment.   
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DNA isolation 
DNA was isolated from all PMA- and EMA-treated samples and from the controls 
according to the method of Wang and Levin (2006).  Following light exposure, all PMA- 
and EMA-treated samples were centrifuged at 8000 g for 5 min (Eppendorf Centrifuge 
5415D, Hamburg, Germany) and the pellets were washed with 250 µl 1.5% (m/v) NaCl 
(Merck) and then with 250 µl distilled water.  Pellets were re-suspended in 250 µl distilled 
water.  Control samples were also centrifuged to harvest the cells and the pellets were re-
suspended in 250 µl distilled water.  All samples were mixed with 250 µl of double-strength 
TZ (2 x TZ) (Abolmatty et al., 2000), which consisted of 4% (v/v) Triton X-100 (Merck) and 
5 mg.ml-1 sodium azide (Merck) in 0.1 M Tris–HCl (Fluka, supplied by Sigma-Aldrich) at pH 
8.0.  Tubes were heated in a boiling waterbath for 10 min to lyse the cells.  Cell debris 
were pelleted by centrifugation at 10 000 g for 5 min and 200 µl of the crude DNA from 
each sample was purified using a Micropure-EZ column (Millipore, supplied by Microsep, 
Cape Town, South Africa).  
 
PCR amplification 
The E. sakazakii-specific primers Esakf (5’ GCT YTG CTG ACG AGT GGC GG 3’) and 
Esakr (5’ ATC TCT GCA GGA TTC TCT GG  3’) were utilised to amplify a fragment of the 
16S ribosomal RNA (rRNA) gene of E. sakazakii (Lehner et al., 2004).  PCR amplification 
was performed in a total volume of 50 µl containing 1 µl (200 nM) of each primer (10 µM), 
0.70 µl (3.5 U) Taq DNA polymerase (5 U.µl-1, Super-Therm, supplied by Southern Cross 
Biotechnologies, Cape Town, South Africa), 5 µl 10 x reaction buffer (MgCl2 free) (Super-
Therm), 3 µl (1.5 mM) MgCl2 (25 mM, Super-Therm), 2 µl (0.4 mM) of dNTPs (10 mM, AB 
gene, supplied by Southern Cross Biotechnologies), 2 µl 99% (v/v) dimethyl sulphoxide 
(DMSO) (Merck) and 4 µl of DNA template.  Thermal cycling was carried out as follows: 
initial denaturation at 94°C for 2 min; followed by 29 cycles of denaturation at 94°C for 30 
sec; primer annealing at 66°C for 1 min; and chain elongation at 72°C for 90 sec.  Final 
elongation was performed at 72°C for 5 min.  The PCR products were separated on a 
1.5% (m/v) agarose gel, containing 0.02 µl.ml-1 ethidium bromide, in 0.5 x TBE 
electrophoresis buffer.  The separated DNA fragments were visualised under an ultraviolet 
transilluminator (Vilber Lourmat, Marne La Vallee, France).  
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PCR product concentration and yield 
PCR products were purified using Sigma Spin Post-Reaction Purification Columns (Sigma-
Aldrich) according to the manufacturer’s instructions.  The concentration of the PCR 
products was fluorometrically determined using a DyNA Quant 200 fluorometer (Hoefer 
Pharmacia Biotech, San Francisco, USA).  The fluorometer was calibrated with a standard 
100 ng.ml-1 DNA solution, which was prepared by adding 2 µl of calf thymus DNA (100 
µg.ml-1, Sigma-Aldrich) to 2 ml assay solution (1 µg.ml-1 Hoechst 33258 dye (Sigma-
Aldrich) in 1 x TNE buffer (0.2 M NaCl (Merck), 10mM Tris-HCl (Fluka), 1 mM EDTA 
(Merck), pH 7.4)).  The DNA concentrations were determined by placing a cuvette 
containing 2 µl sample and 2 ml assay solution into the fluorometer, and recording the 
DNA concentrations. 
In order to compare the effect that PMA and EMA treatments had on the 
concentration of the PCR product amplified from viable and dead cells, the PCR product 
concentration of each sample was compared to the PCR product concentration of a viable, 
untreated sample expected to contain the highest PCR product concentration (Nocker et 
al., 2006).  The PCR product yield (%) was calculated as follows: (PCR product 
concentration of sample in ng.ml-1 / PCR product concentration of viable, untreated control 
in ng.ml-1) x 100. 
 
Statistical analysis  
All statistical analyses were performed using Statistica™ 7.1 (StatSoft, Inc., 2006).  For 
optimisation of the PMA and EMA treatments on either 100% viable or 100% dead  
E. sakazakii cells, a three-way cross-classification analysis of variance (ANOVA) was 
performed.  The factors were the treatment used (PMA, EMA or control receiving no 
treatment), the viability of the cells exposed to treatment (viable, heat-killed or isopropanol-
killed) and the concentration of the PMA or EMA used for treatment (100, 50, 10 or  
0 µg.ml-1).  Since the interaction of the PMA or EMA concentration with the other factors 
was deemed non-significant (P > 0.05), the statistical analysis was repeated using a two-
way ANOVA, with factors being the treatment used and the viability of the cells.  The 
relationship between the percentage of viable cells and the PCR product yields was 
investigated using a two-way ANOVA, with the factors being the percentage of viable and 
heat-killed cells and the treatment used.  Differences were considered statistically 
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significant at a level of 5% (P < 0.05).  Where interactions were non-significant (P > 0.05), 
main effects were interpreted directly.  A Bonferroni multiple comparisons procedure was 
used when interactions were significant in order to interpret which interaction effects 
differed.  Where residuals were not normally distributed, the interactions were further 
analysed using the non-parametric Bootstrap multiple comparisons procedure (Efron & 
Tibshirani, 1993). 
 
Results and discussion 
 
Optimisation of PMA and EMA treatments  
Control samples 
The PCR products (929 base pair (bp) in size) that were amplified from the control DNA 
samples, isolated from either 100% viable or 100% dead (heat- and isopropanol-killed) 
cells, are presented in Fig. 1A (lanes 1-3).  Since these control samples received no PMA 
or EMA treatment, the results represent conventional PCR amplification.  The amplification 
of prominent bands from the viable E. sakazakii cells (lane 1), as well as from the heat-
killed (lane 2) and isopropanol-killed (lane 3) cells, indicate that conventional PCR systems 
amplify DNA from both viable and dead cells. 
The PCR product yields obtained from the viable, heat- and isopropanol-killed control 
samples were 100%, 92% and 83%, respectively.  Statistically, the yields from all three 
control samples differed significantly (P < 0.05) from one another (indicated by the 
subscripts a, b and c, Fig. 1B).  Therefore, even when no PMA or EMA treatment was 
applied, the killing method alone led to a significant reduction in the PCR product yield in 
comparison to the yield from viable cells.  The PCR product yield was significantly  
(P < 0.05) lower when isopropanol was used to kill the cells in comparison to when heating 
was used (Fig. 1B, lane 2 and 3, subscripts b and c).  The significant difference in the PCR 
product yields between the two dead controls may have originated during the cell-killing 
treatments.  A greater proportion of genomic DNA could have been destroyed during 
exposure of E. sakazakii cells to isopropanol than was destroyed during exposure to heat, 
providing less DNA template for PCR amplification.  In spite of the significant differences 
between the PCR product yields from viable and dead controls, it was observed that PCR 
product yields of greater than 80% were obtained from both of the dead controls (Fig. 1B, 
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lanes 2 and 3) compared to the viable cell control (Fig. 1B, lane 1), for which the PCR 
product yield was defined as 100%.  This demonstrates that a substantial amount of DNA 
must have persisted after the heat- or isopropanol-induced death of E. sakazakii cells, 
which served as a template for PCR amplification.  It is the amplification of this persisting 
DNA from dead cells that may lead to false-positive conventional PCR results.   
 
PMA and EMA treated samples 
Successful amplification products were obtained from all PCR reactions containing DNA 
from 100% viable cells that were treated with PMA and EMA (Fig. 1A, lanes 4, 7, 10, 13, 
16, 19).  Since PMA and EMA are unable to penetrate the intact cell membrane of viable 
cells (Rudi et al., 2005; Nocker et al., 2006; Wang & Levin, 2006), successful PCR 
amplification products were expected from samples containing viable cells, regardless of 
whether they were untreated or treated with the intercalating dyes.    PMA and EMA can, 
however, penetrate the compromised cell membranes of dead cells.  Thus, as expected, 
both PMA and EMA treatments inhibited DNA amplification from dead cells (Fig. 1A), 
independent of the killing method employed or the PMA and EMA concentrations added.  
The PCR product yields obtained from the 100% viable cells (Fig. 1B, lanes marked 
V) were higher than those obtained from the dead cells (Fig. 1B, lanes marked H and I) at 
all concentrations (100, 50 or 10 µg.ml-1) of PMA or EMA.  When 100% viable cells were 
treated with 100, 50 and 10 µg.ml-1 PMA (Fig. 1B, lanes 4, 7, 10) the PCR product yields 
were 95%, 96% and 97%, respectively.  These PCR product yields did not differ 
significantly (P > 0.05) from the yield obtained from the 100% viable control that received 
no PMA or EMA treatment (defined as a PCR product yield of 100%) (Fig. 1B, lane 1). 
  Treatment of 100% viable cells with 100, 50 and 10 µg.ml-1 EMA (Fig. 1B, lanes 13, 
16, 19) resulted in PCR product yields of 74%, 82% and 92%, respectively.  In contrast 
with PMA, the PCR product yields from the 100% viable cells treated with EMA at all three 
concentrations were significantly (P < 0.05) lower than that of the 100% viable control (Fig. 
1B, lane 1).  The observation that the PCR product yields from the 100% viable cells 
treated with EMA (Fig. 1B, lanes 13, 16, 19) were significantly (P < 0.05) lower than those 
from the PMA-treated 100% viable cells (Fig. 1B, lanes 4, 7, 10) suggests that the intact 
membrane of viable E. sakazakii cells can effectively exclude PMA, while EMA appears to 
be capable of penetrating these cells.  This explains why less PCR product was amplified 
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from viable cells after EMA treatment in comparison to after PMA treatment.  For PMA- 
and EMA-PCR methods to be most effective, they should bring about complete inhibition 
of DNA amplification from dead cells, yet no significant inhibition of DNA amplification from 
viable cells.  This study demonstrates that, in contrast to EMA, PMA does not significantly 
inhibit PCR amplification from viable E. sakazakii cells. 
With PMA treatments of 100, 50 and 10 µg.ml-1, the respective PCR product yields 
from 100% heat-killed cells (0%, 0% and 6%) (Fig. 1B, lanes 5, 8 and 11) and 100% 
isopropanol-killed cells (0%, 0% and 9%) (Fig. 1B, lanes 6, 9 and 12) were significantly  
(P < 0.05) lower than the yields from 100% viable cells (95%, 96% and 97%) receiving the 
same treatments (Fig. 1B, lanes 4, 7, 10).  Similarly, treatments with EMA (100, 50 or 10 
µg.ml-1) also produced significantly (P < 0.05) lower PCR product yields from 100% heat-
killed cells (0%, 0% and 5%) (Fig. 1B, lanes 14, 17 and 20) and isopropanol-killed cells 
(0%, 0% and 6%) (Fig. 1B, lanes 15, 18 and 21) than from 100% viable cells (95%, 96% 
and 97%) (Fig. 1B, lanes 4, 7, 10).  These results illustrate the ability of PMA and EMA to 
differentiate between viable and dead E. sakazakii cells, and to prevent DNA amplification 
from dead cells. 
  Statistically, the aforementioned PCR product yields obtained from the 100% heat- 
and isopropanol-killed cells treated with PMA and EMA at all three concentrations (100, 50 
and 10 µg.ml-1) (Fig. 1B, lanes 5, 6, 8, 9, 11, 12, 14, 15, 17, 18, 20 and 21) were 
significantly (P < 0.05) lower than the yields of the 100% heat- and isopropanol-killed 
controls (92% and 83%) receiving no PMA or EMA treatment (Fig. 1B, lanes 2 and 3).  It is 
evident that, in comparison to the respective controls (which demonstrate the amplification 
of DNA that occurs from dead cells with conventional PCR), both PMA and EMA were 
capable of significantly reducing the PCR signal from dead E. sakazakii cells.  This shows 
the potential of these DNA-intercalating dyes in PCR applications where detection of only 
viable bacteria is required. 
At a given concentration of PMA or EMA (100 or 50 or 10 µg.ml-1), the PCR product 
yields from the PMA- and EMA-treated heat-killed cells did not differ significantly  
(P > 0.05) from one another (Fig. 1B, comparing the PCR product yields of 0% and 0% in 
lanes 5 and 14; 0% and 0% in lanes 8 and 17; and 6% and 5% in lanes 11 and 20).  
Similar results were obtained with the PMA- and EMA-treated isopropanol-killed cells (Fig. 
1B, comparing the PCR product yields of 0% and 0% in lanes 6 and 15; 0% and 0% in 
lanes 9 and 18; and 9% and 6% in lanes 12 and 21).  Thus, both PMA and EMA 
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Figure 1  The effect of different concentrations of PMA and EMA on the PCR product yield obtained from viable (grey columns) and dead (heat- or 
isopropanol-killed) (black columns) E. sakazakii cells.  (A) PCR products visualised on an agarose gel.  (B) PCR product yields shown in relation 
to the yield obtained from the viable untreated control sample (Lane 1; PCR product yield defined as 100%).  Lanes 1, 2, 3: control samples, 
receiving no EMA or PMA treatment; lanes 4, 5, 6: samples treated with 100 µg.ml-1 PMA; lanes 7, 8, 9: samples treated with 50 µg.ml-1 PMA; 
lanes 10, 11, 12: samples treated with 10 µg.ml-1 PMA; lanes 13, 14, 15: samples treated with 100 µg.ml-1 EMA; lanes 16, 17, 18: samples 
treated with 50 µg.ml-1 EMA; lanes 19, 20, 21: samples treated with 10 µg.ml-1 EMA.  Statistically significant differences (P < 0.05) between PCR 
product yields are indicated by non-identical subscript letters, whereas non-significant differences (P > 0.05) are indicated by identical subscript 
letters. 
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significantly inhibited PCR amplification from heat- and isopropanol-killed cells.  At the 
same PMA and EMA concentrations, there was with no statistical difference (P < 0.05) in 
the efficiency of the two dyes in inhibiting PCR amplification from dead cells.   
The specific concentration of PMA and EMA, however, had a significant effect on the 
efficiency of the treatments in some cases.  The PCR product yields of 0% from 100% 
dead cells treated with either 100 or 50 µg.ml-1 PMA (Fig. 1B, lanes 5, 6, 8, 9) or EMA  
(Fig. 1B, lanes 14, 15, 17, 18) were significantly (P < 0.05) lower than those from 100% 
dead cells treated with 10 µg.ml-1 PMA (6% and 9%) (Fig. 1B, lanes 11 and 12) or EMA 
(5% and 6%) (Fig. 1B, lanes 20 and 21).  The percentage to which PCR amplification was 
inhibited by PMA and EMA treatments indicate that at concentrations of 100 or 50 µg.ml-1, 
there was 100% inhibition of PCR amplification from heat- and isopropanol-killed cells by 
PMA (Fig. 1, lanes 5, 6, 8, 9) and EMA (Fig. 1B, lanes 14, 15, 17, 18).  PMA and EMA 
treatments of 10 µg.ml-1 allowed PCR yields of up to 10% to be amplified from 100% dead 
cells (Fig. 1B, lanes 11, 12, 20, 21).  This indicates that PMA or EMA concentrations of 
100 or 50 µg.ml-1 were more successful in completely inhibiting PCR amplification from 
dead cells.   
The results from the grouped analyses indicate that the most efficient overall 
treatment used for viable/dead discrimination of E. sakazakii was with PMA at a 
concentration of either 100 or 50 µg.ml-1.  Such a treatment would, according to the results 
of this study, not significantly inhibit DNA amplification from viable cells, while bringing 
about complete inhibition of DNA amplification from dead cells. 
 
Effects of PMA and EMA on defined ratios of viable and dead cells 
Controls 
The PCR products (929 bp in size) amplified from the control cell mixtures are presented in 
Fig. 2A (lanes 1-5).  When no PMA or EMA treatment was applied to the control cell 
mixtures containing viable cells at 0, 25, 50, 75 or 100% of the total cell concentration, 
there was no significant (P > 0.05) difference in the PCR product yields obtained (92, 94, 
96, 97 and 100%, respectively) (Fig. 2B, lanes 1-5).  Thus, the PCR product yields of all 
control samples exceeded the percentages of viable cells in the mixtures, demonstrating 
that amplification occurred from the DNA derived from the dead cells.  The concentration 
of the PCR product obtained from the control sample containing a 100% dead cells and 
Stellenbosch University  http://scholar.sun.ac.za
 82 
that containing a 100% viable cells was not significantly different (P > 0.05), indicating that 
a large proportion of DNA can persist after cell death and serve as a template during PCR 
amplification. 
 
PMA- and EMA-treated samples 
The PCR product yields amplified from PMA- and EMA-treated cell mixtures are presented 
in Figure 2B (lanes 6-15).  If PMA and EMA treatments were 100% effective in preventing 
DNA amplification from dead cells, it would be expected that the DNA yields would 
correspond directly with the percentage of viable cells in the sample.  Thus, when viable 
cells constituted 0, 25, 50, 75 or 100% of the total cell concentration, PCR product yields of 
0, 25, 50, 75 or 100%, respectively, would be expected.  The PCR product yields for PMA-
treated cell mixtures containing viable cells at 0, 25, 50, 75 and 100% of the total cell 
concentration were 0, 24, 51, 73 and 97% (Fig. 2B, lanes 6-10), respectively.  Therefore, 
PMA treatments provided successful viable/dead differentiation, and accurately brought 
about selective amplification from the proportion of viable cells present. The corresponding 
PCR product yields from the EMA-treated cell mixtures were 0, 20, 39, 58, and 71%, 
respectively (Fig. 2A, lanes 11-15), which were considerably lower than expected.  The 
consistently lower PCR product yields obtained from cell mixtures containing increasing 
numbers of viable cells is again indicative of the inhibitory effect that EMA had on PCR 
amplification from viable cells.    
When cell mixtures contained 0% viable cells, there was a significant (P > 0.05) 
difference between the PCR product yields from the control sample receiving no treatment 
and the yields from the samples treated with PMA and EMA (Fig. 2B, comparing the PCR 
product yields of 92%, 0% and 0% in lanes 1, 6 and 11 respectively).  Similarly, when cell 
mixtures contained 25% viable cells, there was a significant (P > 0.05) difference between 
the PCR product yields from the control sample and the yields from the samples treated 
with PMA and EMA (Fig. 2B, comparing the PCR product yields of 94%, 24% and 20% in 
lanes 2, 7 and 12 respectively).  At these ratios of viable to dead cells (0:100 and 25:75), 
there was no significant (P > 0.05) difference between the PCR product yields obtained 
from the samples treated with PMA and those treated with EMA (Fig. 2B, comparing 0% 
and 0% in lanes 6 and 11; and comparing 24% and 20% in lanes 7 and 12).  Thus, PMA 
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and EMA had similar efficiencies in preventing PCR amplification from dead cells when low 
concentrations of viable cells were present in the mixtures. 
  When cell mixtures contained 50% viable cells, there was a significant difference 
between the PCR product yields from the control samples (receiving no treatment) and the 
yields from the samples treated with PMA and EMA (Fig. 2B, comparing the PCR product 
yields of 96%, 51% and 39% in lanes 3, 8 and 13, respectively).  Similarly, when cell 
mixtures contained 75% viable cells, there was a significant difference between the PCR 
product yields from the control samples and the yields from the samples treated with PMA 
and EMA (Fig. 2B, comparing the PCR product yields of 97%, 73% and 58% in lanes 4, 9 
and 14, respectively).  However, at these ratios of viable to dead cells (50:50 and 75:25), 
the PCR product yields obtained from PMA-treated cells were significantly (P < 0.05) 
higher than those obtained from EMA-treated cells (Fig. 2B, comparing 51% and 39% in 
lanes 8 and 13; and comparing 73% and 58% in lanes 9 and 14).  When cell mixtures 
contained 100% viable cells, there was no significant difference (P > 0.05) between the 
PCR product yield of 100% from the control (Fig. 2B, lane 5) and the yield of 97% from the 
PMA-treated sample (Fig. 2B, lane 10).  However, at this ratio of viable to dead cells 
(100:0), the PCR product yield of 71% from the EMA-treated sample (Fig. 2B, lane 15) was 
significantly (P < 0.05) lower than the yield of 100% from the control (Fig. 2B, lane 5) and 
the yield of 97% from the PMA-treated sample (Fig. 2B, lane 10).   
Evaluation of the efficacy of PMA-PCR and EMA-PCR on mixtures of viable and 
dead cells demonstrated that PMA is effective in selectively allowing PCR amplification 
from viable cells when in the presence of DNA from dead cells.  In contrast, EMA was 
shown to significantly inhibit PCR amplification from viable cells, as well as from dead 
cells.  Although an intact cell membrane should be an effective barrier to EMA because of 
the charge of the molecule, various reports (Nocker & Camper, 2006; Nocker et al., 2006) 
have also suggested that EMA may penetrate viable cells of some bacterial species.  The 
first report of EMA inhibiting PCR amplification from viable cells was made for the 
bacterium Anoxybacillus (Rueckert et al., 2005). Nocker et al. (2006) subsequently 
reported that although EMA and PMA were equally efficient in preventing PCR 
amplification from dead Staphylococcus aureus, Listeria monocytogenes, Micrococcus 
luteus, Mycobacterium avium and Streptococcus sobrinus cells, EMA also caused 
inhibition of PCR amplification from viable cells of these species.  These studies indicate 
that EMA cannot be considered to be membrane impermeable for all bacterial species.
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PMA appears to have the advantage over EMA of not penetrating membranes of viable 
cells, yet effectively entering damaged or dead cells (Nocker & Camper, 2006).  The 
enhanced selectivity of PMA is most likely due to the higher charge of the PMA molecule 
(PMA has two positive charges, while EMA has only one), and the greater impermeability 
through the intact cell membrane (Nocker et al., 2006).  
 
Conclusions 
 
This is the first report on the development of a PCR-based technique for selectively 
amplifying a targeted DNA sequence from only viable E. sakazakii cells in the presence of 
dead cells.  The ability to selectively amplify DNA from only viable and not dead cells shall 
significantly enhance the utility of PCR for rapidly determining and quantifying targeted 
viable micro-organisms of public health concern in food products, food processing facilities, 
and in environmental and clinical samples.  This study demonstrated that the utility of EMA 
for viable/dead differentiation of E. sakazakii is hindered by the penetration of viable cells 
by the dye, and the resulting decreased PCR product yields.  In contrast, the PMA-PCR 
method described appears highly effective for this purpose.  The assays described in this 
study allow qualitative viable/dead differentiation in pure cultures of E. sakazakii.  For 
future applications, however, the method should be adapted for quantitative viable/dead 
differentiation in mixed bacterial cultures by using quantitative real-time PCR.    Such a 
method would aid in attaining a greater understanding of the resistance and survival 
strategies of E. sakazakii in foods and in the environment, as well as the stress responses 
of the pathogen to various inactivation and preservation treatments.  This would be an 
important step in the efforts to eliminate it from food production environments. 
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CHAPTER 5 
 
GENERAL DISCUSSION AND CONCLUSIONS 
 
Enterobacter sakazakii is an emerging pathogen associated with life-threatening neonatal 
infections, predominantly through the consumption of contaminated powdered infant 
formula milk (IFM) (Nazorowec-White & Farber, 1997; Iversen & Forsythe, 2003).  While  
E. sakazakii poses a considerable food safety threat worldwide, developing countries such 
as South Africa are often at the highest risk for foodborne infections (FAO/WHO, 2004).  
The risks posed by foodborne pathogens are increased by the fact that many individuals 
living in developing countries do not have access to adequate storage and refrigeration 
facilities and many are ignorant with regards to hygienic food handling practices.  
Furthermore, reduced immunity due to HIV-infections and malnutrition affect many 
individuals in developing countries, making them susceptible to foodborne infections 
(INFOSAN, 2005).   
To date, there have been no official reports of E. sakazakii infections occurring in 
South Africa.  However, considering the limitations of the current surveillance systems in 
most developing countries, official documentation may not always adequately reflect the 
true prevalence of foodborne diseases in these countries (FAO/WHO, 2004).  Given the 
widespread use of IFM in South Africa and the considerable proportion of immuno-
compromised individuals, the identification of E. sakazakii in South African IFM products 
(Witthuhn et al., 2006) should warrant cause for concern. 
At present, the monitoring of IFM products for the presence of E. sakazakii, and the 
assurance that these products are free of the pathogen, remains a great challenge for food 
manufacturers.  This is largely due to the fact that there are no validated or official methods 
available for the detection of E. sakazakii (Nazorowec-White et al., 2003).  Furthermore, 
the prevailing microbiological food standards do not require the specific testing for E. 
sakazakii, nor do they specify allowable levels for the pathogen in food products 
(FAO/WHO, 2004; INFOSAN, 2005).  The contradictory results obtained with different 
detection methods not only lead to financial losses to food manufacturers, but also lead to 
confusion regarding this pathogen.  There is thus a need for an accurate, internationally 
validated method for the detection and identification of E. sakazakii in food products.  
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The current Food and Drug Administration (FDA, 2002) method for E. sakazakii 
detection requires revision, particularly with regard to the identification and confirmation of 
presumptive E. sakazakii isolates.  This was demonstrated by the low sensitivity, specificity 
and overall accuracy of utilising yellow pigment production as a criterion for identification of 
E. sakazakii.  More rapid, sensitive, specific and accurate selective chromogenic media 
have been developed for E. sakazakii detection (Iversen & Forsythe, 2004; Iversen et al., 
2004), and their has recently been increased utilisation of molecular methods such as 
species-specific PCR and DNA sequencing for the identification of microbial pathogens 
(Olsen et al., 1995; Van Belkum et al., 2001)   
Based on the results obtained in this study, a new method is proposed for the 
detection and identification of E. sakazakii in food and in environmental samples.  In this 
proposed method (Fig. 1), the culturing steps on violet red bile glucose agar (VRBGA) and 
tryptone soy agar (TSA) used in the FDA method are replaced by culturing on selective 
chromogenic Druggan-Forsythe-Iversen (DFI) or Enterobacter sakazakii (ES) agar.  For 
identification and confirmation of presumptive E. sakazakii isolates, it is proposed that the 
use of the oxidase test, yellow pigment production and API biochemical profiling be 
replaced by species-specific PCR and/or DNA sequencing.  Species-specific PCR should 
be carried out with the primer pair Esakf and Esakr, which was demonstrated in this study 
to be the most suitable primer pair for the detection of E. sakazakii.  This proposed method 
will not only reduce the time to detect E. sakazakii from approximately 7 days to 4 days, but 
it will also be more sensitive, specific and accurate than the current FDA method.  With the 
availability of the more accurate method proposed for E. sakazakii detection, it is further 
recommended that specific microbiological standards for E. sakazakii be introduced into 
food regulations (Iversen & Forsythe, 2003).  The recent introduction of microbiological 
standards for E. sakazakii in powdered IFM by the European Union (negative in 30 x 10g 
samples) (EC, 2005), could be useful in establishing similar specifications worldwide.   
  While the introduction of an accurate method for E. sakazakii detection will greatly aid 
in reducing the risks associated with the pathogen, efficient inactivation and preservation 
techniques are needed to reduce the prevalence of the bacterium in food products.  In 
order to assess the effectiveness of such inactivation techniques, accurate methods are 
required to validate the killing effect of the treatments.  The PMA-PCR methodology 
developed in this study will be particularly useful for assessing the efficacy of processing
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Figure 1   Comparison of the FDA method and a proposed new method for E. sakazakii detection, based on the results 
obtained in this study.
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techniques, such as irradiation or reconstitution of IFM with water at 70°C, on inactivating 
E. sakazakii in food products.  The PMA-PCR method will greatly aid in monitoring the 
resistance, survival strategies and stress responses of E. sakazakii.  This would be an 
important step in the efforts to eliminate E. sakazakii from food and food production 
environments. 
 
Concluding remarks 
Human infants are so susceptible to infection that products such as IFM must be 
manufactured and monitored according to strict food safety standards to ensure that they 
are safe for consumption.  The presence of E. sakazakii in IFM constitutes a significant risk 
to infant health if conditions after product reconstitution allow the bacterium to multiply to 
infectious levels.   
The FDA method presently recommended for the detection of E. sakazakii in IFM is 
inadequate and non-specific.  A new method has been proposed for detection of this 
bacterium based on a comprehensive evaluation of a variety of currently available 
detection methods.  This method is not only more sensitive, specific and accurate for E. 
sakazakii detection than the current FDA method, but it also considerably reduces the time 
taken to detect this pathogen.  The introduction of more stringent microbiological 
standards, together with the use of a more accurate method for E. sakazakii detection are 
recommended to reduce the health risks currently posed by this pathogen.   
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